Data Science Funding Announcements & Notices

Data science and informatics funding announcements and notices are available from NCI and NIH programs. Browse below for opportunities, requests for information, notices, and initiatives.

Title FOA Organization Release Date Expire Date Purpose
Innovative Research in Cancer Nanotechnology (IRCN) (R01 Clinical Trial Not Allowed) PAR-20-284 NCI This Funding Opportunity Announcement (FOA) entitled "Innovative Research in Cancer Nanotechnology (IRCN)" encourages applications promoting transformative discoveries in cancer biology and… More
Precompetitive Collaboration on Liquid Biopsy for Early Cancer Assessment: Data Management and Coordinating Unit (U24 Clinical Trial Not Allowed) RFA-CA-23-031 NCI The objectives of the Early Detection Research Network (EDRN; edrn.cancer.gov) are to discover, develop and validate biomarkers and imaging methods to detect early stage cancers and to translate… More
National Cancer Institute Program Project Applications (P01 Clinical Trial Optional) PAR-20-077 NCI With this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) invites applications for investigator-initiated Program Project (P01) applications. The proposed Program may… More
Notice of Special Interest (NOSI): Dietary, Physical Activity, Sedentary Behavior and Sleep Assessment Methodologies Among Infants and Young Children (Birth to 5 years) through Adults NOT-CA-21-108 NCI The purpose of this NOSI is to invite investigator-initiated applications addressing approaches that improve the measurement of diet, physical activity, sedentary behavior, and sleep and their… More
Notice of Special Interest (NOSI): Single-Cell Proteomics for Interrogating Premalignant and Early Malignant Lesions NOT-CA-20-044 NCI Notice Special Interest NOSI): Single-Cell Proteomics Interrogating Premalignant Early Malignant Lesions Notice Number: NOT-CA-20-044 Key Dates Release Date: April 09, 2020 First Available Due Date… More
Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed) PAR-20-131 NCI The purpose of this Funding Opportunity Announcement (FOA) is to invite applications for projects to expand, improve, or transform the utility of mammalian cancer and tumor models for translational… More
Notice of Special Interest (NOSI): Advancing Cancer Data Repositories and Knowledgebases NOT-CA-20-045 NCI Notice Special Interest NOSI): Advancing Cancer Data Repositories Knowledgebases Notice Number: NOT-CA-20-045 Key Dates Release Date: April 09, 2020 First Available Due Date: September 25, 2020… More
New Informatics Tools and Methods to Enhance U.S. Cancer Surveillance Research (U01 Clinical Trial Optional) PAR-20-170 NCI The goal of this Funding Opportunity Announcement (FOA) is to advance surveillance science by supporting the development of new and innovative tools and methods for more efficient, detailed, timely,… More
Addressing the Primary Care Needs of Cancer Survivors (U01 Clinical Trial Required) RFA-CA-23-025 NCI The purpose of this RFA is to support the development and testing of primary care practice- and health system-level interventions and strategies to promote high quality care for adult cancer… More
Cancer Adoptive Cellular Therapy Network (Can-ACT) for Adult Cancers (UG3/UH3 Clinical Trial Required) RFA-CA-22-028 NCI The National Cancer Institute (NCI) intends to promote a new initiative by publishing a Funding Opportunity Announcement (FOA) soliciting UG3/UH3 applications for the Cancer Adoptive Cellular Therapy… More
Cancer Adoptive Cellular Therapy Network (Can-ACT) for Pediatric Cancers (UG3/UH3 Clinical Trial Required) RFA-CA-22-029 NCI The National Cancer Institute (NCI) intends to promote a new initiative by publishing a Funding Opportunity Announcement (FOA) soliciting UG3/UH3 applications for the Cancer Adoptive Cellular Therapy… More
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional) RFA-CA-23-006 NCI The purpose of this Funding Opportunity Announcement (FOA) is to encourage revision applications (formerly called "competing revisions") from currently funded NCI R01 research projects. The… More
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) RFA-CA-23-002 NCI This Funding Opportunity Announcement (FOA) solicits grant applications proposing exploratory research projects focused on the early-stage development of highly innovative technologies offering novel… More
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trials Optional) RFA-CA-23-008 NCI The purpose of this Funding Opportunity Announcement (FOA) is to encourage revision applications (formerly called "competing revisions") from currently funded NCI U54 Resource-Related… More
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) RFA-CA-23-003 NCI This Funding Opportunity Announcement (FOA) solicits grant applications proposing exploratory research projects focused on further development and validation of emerging technologies offering novel… More
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional) RFA-CA-23-011 NCI The purpose of this Funding Opportunity Announcement (FOA) is to encourage revision applications (formerly called "competing revisions") from currently funded NCI U2C Resource-Related Multi… More
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) RFA-CA-23-005 NCI This Funding Opportunity Announcement (FOA) solicits grant applications proposing exploratory research projects focused on further development and validation of emerging technologies that improve the… More
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional) RFA-CA-23-009 NCI The purpose of this Funding Opportunity Announcement (FOA) is to encourage revision applications (formerly called "competing revisions") from currently funded NCI P01 program projects. The… More
Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional) RFA-CA-23-007 NCI The purpose of this Funding Opportunity Announcement (FOA) is to encourage revision applications (formerly called "competing revisions") from currently funded NCI U01 research projects. The… More
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional) RFA-CA-23-010 NCI The purpose of this Funding Opportunity Announcement (FOA) is to encourage revision applications (formerly called "competing revisions") from currently funded NCI P50 specialized centers.… More
Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) RFA-CA-23-004 NCI This Funding Opportunity Announcement (FOA) solicits grant applications proposing exploratory research projects focused on the early-stage development of highly innovative technologies that improve… More
Tobacco Control Policies to Promote Health Equity (R21 Clinical Trial Optional) PAR-20-303 NCI The purpose of this Funding Opportunity Announcement (FOA) is to support observational or intervention research focused on reducing disparities in tobacco use and secondhand smoke (SHS) exposure in… More
Tobacco Control Policies to Promote Health Equity (R01 Clinical Trial Optional) PAR-20-302 NCI The purpose of this Funding Opportunity Announcement (FOA) is to support observational or intervention research focused on reducing disparities in tobacco use and secondhand smoke (SHS) exposure in… More
National Cancer Institute Youth Enjoy Science Research Education Program (R25 Clinical Trial Not Allowed) RFA-CA-21-020 NCI The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this National Cancer Institute (NCI) R25 program is to… More
Research to Understand and Address the Survivorship Needs of Individuals Living with Advanced Cancer (R01 Clinical Trial Optional) RFA-CA-22-027 NCI The purpose of this Funding Opportunity Announcement (FOA) is to invite applications that aim to understand and address the survivorship needs of individuals living with likely incurable cancers.… More
NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed) PAR-21-306 NCI This Funding Opportunity Announcement (FOA) invites grant applications for the Research Specialist Award (R50) specifically for clinician scientists supporting NCI-funded clinical trials research.… More
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed) PAR-20-313 NCI Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) invites applications to support the validation of molecular/cellular/imaging markers (referred to as "… More
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed) PAR-20-314 NCI The purpose of this Funding Opportunity Announcement (FOA) is to accelerate the adoption and validation of molecular/cellular/imaging markers (referred to as "markers" or "biomarkers… More
Advancing Adolescent Tobacco Cessation Intervention Research (R34 Clinical Trial Optional) RFA-CA-22-042 NCI The purpose of this RFA is to stimulate research on the development and evaluation of tobacco cessation interventions for adolescents, with an emphasis on ages 14-20. We have chosen to focus on this… More
Advancing Adolescent Tobacco Cessation Intervention Research (R01 Clinical Trial Required) RFA-CA-22-043 NCI The purpose of this Funding Opportunity Announcement (FOA) is to support studies that develop, test, implement, and evaluate behavioral tobacco cessation interventions for adolescents, with a focus… More
Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed) PAR-23-088 NCI The purpose of this Funding Opportunity Announcement (FOA) is to accelerate the pace of translation of NCI-supported methods/assays/technologies (referred to as "assays") to the clinic.… More
Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) RFA-CA-23-017 NCI The purpose of this Funding Opportunity Announcement (FOA) is to invite Cooperative Agreement (U24) applications for the continued development and sustainment of high-value informatics research… More
Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional) RFA-CA-23-015 NCI The goal of this FOA is to advance cancer model systems that recapitulate human immunity in the tumor microenvironment to improve the predictivity of immuno-oncology studies. Proposed research… More
Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional) RFA-CA-23-014 NCI The purpose of this Funding Opportunity Announcement (FOA) is to invite exploratory/developmental research grant applications (R21) for innovative informatics methods and algorithms to improve the… More
Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) RFA-CA-23-016 NCI The purpose of this Funding Opportunity Announcement (FOA) is to invite Cooperative Agreement (U24) applications for advanced development and enhancement of emerging informatics technologies to… More
Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed) PAR-21-061 NCI This Funding Opportunity Announcement (FOA) represents the continuation of an NCI program to enhance the diversity of the pool of the cancer research workforce by recruiting and supporting eligible… More
Basic/Translational Research on Health Disparities in Underrepresented People Living with HIV (PLWH) and Cancer (R21 Clinical Trial Not Allowed) RFA-CA-22-057 NCI Through this funding opportunity announcement, the National Cancer Institute (NCI) intends to focus on the biological interactions of cancer health disparities in people living with HIV (PLWH) from… More
The role of Epstein Barr virus (EBV) infection in Non-Hodgkin Lymphoma (NHL) and Hodgkin disease (HD) development with or without an underlying HIV infection (U01 Clinical Trial Optional) PAR-21-348 NCI The role of EBV infection on Non-Hodgkin Lymphoma (NHL) and Hodgkin disease (HD) development with or without an underlying HIV infection and AIDS will increase our understanding through mechanistic,… More
Basic/Translational Research on Health Disparities in Underrepresented People Living with HIV (PLWH) and Cancer (R01 Clinical Trial Not Allowed) RFA-CA-22-056 NCI Through this funding opportunity announcement, the National Cancer Institute (NCI) intends to focus on the biological interactions of cancer health disparities in people living with HIV (PLWH) from… More
Cancer Research Education Grants Program - Curriculum or Methods Development (R25 Clinical Trial Not Allowed) PAR-21-065 NCI The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NCI R25 program is to support educational activities… More
Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2021, 2022, and 2023 (P50 Clinical Trial Required) PAR-20-305 NCI Through this funding opportunity announcement (FOA), the National Cancer Institute (NCI) invites applications for P50 Research Center Grants for Specialized Programs of Research Excellence (SPORE).… More
Notice of Special Interest (NOSI): Leveraging Real-World Imaging Data for Artificial Intelligence-based Modeling and Early Detection of Abdominal Cancers NOT-CA-21-028 NCI The purpose of this Notice of Special Interest (NOSI) is to solicit applications to support the secondary use of real-world data for Artificial Intelligence (AI)-based predictive modeling with the… More
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required) PAR-21-033 NCI The purpose of this Funding Opportunity Announcement (FOA) is to seek research projects that implement early phase (Phase 0, I, and II) investigator-initiated clinical trials focused on cancer-… More
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed) PAR-21-166 NCI The purpose of this Funding Opportunity Announcement (FOA) is to stimulate efforts to translate scientific discoveries and engineering developments into methods or tools that address problems in… More
Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required) PAR-21-035 NCI Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) invites applications for support of investigator-initiated clinical trials that have the potential to reduce… More
NCI Cancer Moonshot Scholars Diversity Program (CMSDP) (R01 Clinical Trial Optional) RFA-CA-22-050 NCI This Funding Opportunity Announcement (FOA) supports the Cancer Moonshot Scholars Diversity Program (CMSDP) and solicits R01 grant applications that propose independent research projects within the… More
Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional) PAR-21-190 NCI This funding opportunity announcement (FOA) encourages applications for research in cancer control and population sciences. The overarching goal is to provide support to promote research efforts on… More
Notice of Special Interest (NOSI): Validation of Digital Health and Artificial Intelligence Tools for Improved Assessment in Epidemiological, Clinical, and Intervention Research NOT-CA-22-037 NCI The purpose of this Notice of Special Interest (NOSI) is to encourage grant applications to support the evaluation of the utility and validity of digital health and artificial intelligence (AI) tools… More
The NCI Transition Career Development Award (K22 Independent Basic Experimental Studies with Humans Required) PAR-21-318 NCI This Funding Opportunity Announcement (FOA) represents the continuation of an NCI program to facilitate the transition of investigators in mentored, non-independent cancer research positions to… More
The NCI Transition Career Development Award (K22 - Independent Clinical Trial Required) PAR-21-111 NCI This Funding Opportunity Announcement (FOA) represents the continuation of an NCI program to facilitate the transition of investigators in mentored, non-independent cancer research positions to… More
The NCI Transition Career Development Award (K22 - Independent Clinical Trial Not Allowed) PAR-21-128 NCI This Funding Opportunity Announcement (FOA) represents the continuation of an NCI program to facilitate the transition of investigators in mentored, non-independent cancer research positions to… More
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional) PAR-21-206 NCI The purpose of this Funding Opportunity Announcement (FOA) is to stimulate efforts to translate scientific discoveries and engineering developments into methods or tools that address problems in… More
Pancreatic Cancer Detection Consortium: Management and Data Coordination Unit (U24 Clinical Trial Not Allowed) PAR-21-335 NCI The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for the Research Units (RUs), one of the two scientific components of the Pancreatic Cancer Detection Consortium… More
Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional) PAR-21-334 NCI The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for the Research Units (RUs), one of the two scientific components of the Pancreatic Cancer Detection Consortium… More
NCI Transition Career Development Award to Promote Diversity (K22 Independent Clinical Trial Not Allowed) PAR-21-301 NCI The purpose of the NCI Transition Career Development Award to Promote Diversity (K22) is to assist postdoctoral fellows or individuals in equivalent positions to transition to positions of assistant… More
Basic Research in Cancer Health Disparities (R03 Clinical Trial Not Allowed) PAR-21-324 NCI This Funding Opportunity Announcement (FOA) encourages grant applications from investigators interested in conducting basic, mechanistic research into the biological/genetic causes of cancer health… More
Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed) PAR-21-332 NCI Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) invites applications for support of investigator-initiated studies addressing mechanisms by which bariatric… More
NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 Clinical Trial Required) PAR-21-299 NCI The purpose of the NCI Mentored Clinical Scientist Career Development Award (K08) program is to prepare individuals for careers that have a significant impact on the health-related research needs of… More
Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed) PAR-21-322 NCI This Funding Opportunity Announcement (FOA) encourages grant applications from investigators interested in conducting basic, mechanistic research into the biological/genetic causes of cancer health… More
Cancer Research Education Grants Program - Courses for Skills Development (R25 Clinical Trial Not Allowed) PAR-21-278 NCI The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NCI R25 program is to support educational activities… More
NCI Transition Career Development Award to Promote Diversity (K22 Clinical Trial Required) PAR-21-302 NCI The purpose of the NCI Transition Career Development Award to Promote Diversity is to assist postdoctoral fellows or individuals in equivalent positions to transition to positions of assistant… More
Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed) PAR-21-294 NCI The purpose of this Funding Opportunity Announcement (FOA) is to invite research grant applications (R01) for the development and use of current and emerging molecular imaging methods to gain… More
Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional) PAR-21-331 NCI Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) invites applications for support of investigator-initiated studies addressing mechanisms by which bariatric… More
NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 Independent Clinical Trial Not Allowed) PAR-21-300 NCI The purpose of the NCI Mentored Clinical Scientist Career Development Award (K08) program is to prepare individuals for careers that have a significant impact on the health-related research needs of… More
Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed) PAR-21-323 NCI This Funding Opportunity Announcement (FOA) encourages grant applications from investigators interested in conducting basic, mechanistic research into the biological/genetic causes of cancer health… More
Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional) PAR-21-290 NCI Through this funding opportunity announcement (FOA), the National Cancer Institute (NCI) seeks research project (R01) grant applications describing projects that integrate imaging and fluid-based… More
Cancer Research Education Grants Program - Research Experiences (R25 Clinical Trial Not Allowed) PAR-21-279 NCI The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NCI R25 program is to support educational activities… More
Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed) PAR-22-049 NCI This Funding Opportunity Announcement (FOA) will support extramural research to investigate and mitigate challenges facing clinical assay development and subsequent analytical validation due to… More
Exploratory Grants in Cancer Control (R21 Clinical Trial Optional) PAR-21-341 NCI This funding opportunity announcement (FOA) encourages the submission of exploratory/developmental research grant (R21) applications that focus on different aspects of cancer control by modifying… More
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed) PAR-21-330 NCI This Funding Opportunity Announcement (FOA) encourages the submission of applications that propose to advance research in cancer etiology and early detection biomarkers, utilizing the advantages of… More
Research Projects in Physical Sciences-Oncology (U01 Clinical Trial Optional) PAR-22-147 NCI Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) invites U01 cooperative agreement applications for Physical Sciences-Oncology Network (PS-ON). The goal of the… More
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional) PAR-21-329 NCI The purpose of this Funding Opportunity Announcement (FOA) is to support collaborative research projects designed to address adverse sequelae of cancer therapies that persist and become chronic… More
NCI Outstanding Investigator Award (R35 Clinical Trial Optional) RFA-CA-22-045 NCI This Funding Opportunity Announcement (FOA) invites grant applications for the Outstanding Investigator Award (R35) in any area of cancer research.The objective of the National Cancer Institute (NCI… More
NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Clinical Trial Required) PAR-21-296 NCI This Funding Opportunity Announcement (FOA) is a continuation of the NCI Mentored Research Scientist Development Award to Promote Diversity (K01) to enhance the diversity of thought in the NCI-funded… More
NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Independent Clinical Trial Not Allowed) PAR-21-295 NCI This Funding Opportunity Announcement (FOA) is a continuation of the NCI Mentored Research Scientist Development Award to Promote Diversity (K01) to enhance the diversity of thought in the NCI-funded… More
Toward Translation of Nanotechnology Cancer Interventions (TTNCI) (R01 Clinical Trial Not Allowed) PAR-22-071 NCI This Funding Opportunity Announcement (FOA), entitled "Toward Translation of Nanotechnology Cancer Interventions" (TTNCI), encourages applications for advanced pre-clinical research,… More
Method to Extend Research in Time (MERIT) Award Extension Request (Type 4 Clinical Trial Optional) PAR-21-138 NCI The National Cancer Institute (NCI) Method to Extend Research in Time (MERIT) (R37) Award provides extended grant support to Early Stage Investigators (ESIs). By providing such an opportunity for… More
Notice of Special Interest (NOSI): Technologies and Informatics Tools for Cancer Metabolomics NOT-CA-22-083 NCI This Notice of Special Interest (NOSI) is to alert the community that the National Cancer Institute (NCI) is seeking to support development of innovative technologies and informatics tools for… More
Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional) PAR-21-321 NCI This Funding Opportunity Announcement (FOA) invites applications for P30 Cancer Center Support Grants (CCSGs) to support NCI-designated Cancer Centers. CCSGs support three types of Cancer Centers: 1… More
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed) PAR-22-090 NCI The purpose of this engineering-oriented funding opportunity announcement (FOA) is to encourage submissions of exploratory/developmental Bioengineering Research Grant (EBRG) applications to… More
Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer (R21 Clinical Trial Not Allowed) PAR-22-062 NCI The purpose of this Funding Opportunity Announcement (FOA) is to support exploratory/development basic research projects that elucidate mechanisms by which the human microbiome inhibit or enhance… More
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional) PAR-22-091 NCI The purpose of this engineering-oriented funding opportunity announcement (FOA) is to encourage submissions of exploratory/developmental Bioengineering Research Grant (EBRG) applications to… More
Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer (R01 Clinical Trial Not Allowed) PAR-22-061 NCI The purpose of this Funding Opportunity Announcement (FOA) is to support basic research that elucidates mechanisms by which the human microbiome inhibit or enhance anti-tumor immune responses, and to… More
Research Opportunities in Established Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed) PAR-22-162 NCI Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) encourages grant applications to support cancer epidemiology research in established cohort studies, defined… More
Cancer Epidemiology Cohorts: Building the Next Generation of Research Cohorts (U01 Clinical Trial Not Allowed) PAR-22-161 NCI Through this funding opportunity announcement, the National Cancer Institute (NCI) solicits applications to Cancer Epidemiology Cohorts: Building the Next Generation of Research Cohorts PAR. This… More
Dissemination and Implementation Research in Health (R01 Clinical Trial Optional) PAR-22-105 NCI The purpose of this Funding Opportunity Announcement (FOA) is to support studies that will identify, develop, and/or test strategies for overcoming barriers to the adoption, adaptation, integration,… More
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional) PAR-22-099 NCI This Funding Opportunity Announcement (FOA) will support the development and characterization of state-of-the-art biomimetic tissue-engineered technologies for cancer research. Collaborative,… More
Microbial-based Cancer Imaging and Therapy - Bugs as Drugs (R21 Clinical Trial Not Allowed) PAR-22-086 NCI This Funding Opportunity Announcement (FOA) solicits grant applications proposing to utilize bacteria, archaebacteria, bacteriophages, or other non-oncolytic viruses and their natural products to… More
Dissemination and Implementation Research in Health (R21 Clinical Trial Optional) PAR-22-109 NCI The purpose of this Funding Opportunity Announcement (FOA) is to support studies that will identify, develop, and/or test strategies for overcoming barriers to the adoption, adaptation, integration,… More
Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R01 Clinical Trial Not Allowed) PAR-22-139 NCI The purpose of this Funding Opportunity Announcement (FOA) is to solicit R01 research projects utilizing state-of-the-art cancer biology methods and model systems to study effects of different types… More
Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R01 Clinical Trial Not Allowed) PAR-22-083 NCI The purpose of this Funding Opportunity Announcement (FOA) is to promote epidemiologic research investigating novel and innovative hypotheses on emerging risk factors (biological, environmental, and… More
Microbial-based Cancer Imaging and Therapy - Bugs as Drugs (R01 Clinical Trial Not Allowed) PAR-22-085 NCI This Funding Opportunity Announcement (FOA) solicits grant applications proposing to utilize bacteria, archaebacteria, bacteriophages, or other non-oncolytic viruses and their natural products to… More
Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R21 Clinical Trial Not Allowed) PAR-22-140 NCI The STRIPE program seeks to support pre-clinical research projects utilizing state-of-the-art cancer biology methods and model systems that study how radiopharmaceutical therapy (RPT) agents affect… More
Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R21 Clinical Trial Not Allowed) PAR-22-084 NCI The purpose of this Funding Opportunity Announcement (FOA) is to promote epidemiologic research investigating novel and innovative hypotheses on emerging risk factors (biological, environmental, and… More
Discovery and Development of Natural Products for Cancer Interception and Prevention (UG3/UH3 Clinical Trial Not Allowed) RFA-CA-23-028 NCI The overall goal of this UG3/UH3 Exploratory/Developmental phased initiative is to support the discovery and development of novel natural products that are safe, nontoxic, and efficacious for cancer… More
The Metastasis Research Network (MetNet): MetNet Research Projects (U01 Clinical Trial Not Allowed) PAR-22-234 NCI The MetNet is a collection of Research Centers that support using systems level approaches to understand the non-linear, dynamic and emergent processes in metastasis. Considering chronological… More
NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional) PAR-22-216 NCI This Funding Opportunity Announcement (FOA) supports the development of new exploratory research in cancer diagnosis, treatment, imaging, symptom/toxicity, and prevention clinical trials; correlative… More
Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional) PAR-22-174 NCI The purpose of this FOA is to facilitate well planned clinical trials across the cancer prevention and control spectrum aimed at improving prevention/ interception, cancer-related health behaviors,… More
Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed) PAR-22-106 NCI The purpose of this Funding Opportunity Announcement (FOA) is to support studies that will identify, develop, and/or test strategies for overcoming barriers to the adoption, adaptation, integration,… More
Biology of Bladder Cancer (R21 Clinical Trial Optional) PAR-22-219 NCI This Funding Opportunity Announcement (FOA) solicits applications investigating the biology and underlying mechanisms of bladder cancer. Bladder cancer is a significant health problem both in the… More
Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional) PAR-22-243 NCI The purpose of this funding opportunity announcement is to encourage collaborations between the life and physical sciences that: 1) apply a multidisciplinary bioengineering approach to the solution… More
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R01 Clinical Trial Optional) PAR-22-164 NCI Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) announces its interest in supporting meritorious research projects in three distinct domains related to cancer… More
Precision Approaches in Radiation Synthetic Combinations (PAIRS, R01 Clinical Trial Optional) PAR-22-198 NCI The purpose of this Funding Opportunity Announcement (FOA) is to solicit R01 research projects that investigate actionable synthetic vulnerabilities that can be conditionally paired with tumor… More
Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional) PAR-22-173 NCI The purpose of this FOA is to facilitate well planned clinical trials across the cancer prevention and control spectrum aimed at improving prevention/ interception, cancer-related health behaviors,… More
Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Cancer and Precancerous Lesions Associated with Lethal Phenotypes (R01 Clinical Trial Optional) PAR-22-131 NCI This Funding Opportunity Announcement (FOA) will support the development of state-of-the-art projects that integrate imaging, biomarkers, digital pathomics, glycomics, metabolomics, other omic… More
Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed) PAR-22-242 NCI The purpose of this funding opportunity announcement is to encourage collaborations between the life and physical sciences that: 1) apply a multidisciplinary bioengineering approach to the solution… More
Precision Approaches in Radiation Synthetic Combinations (PAIRS, R21 Clinical Trial Optional) PAR-22-199 NCI Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) will solicit R01 research projects that seek to investigate actionable synthetic vulnerabilities that can be… More
Biology of Bladder Cancer (R01 Clinical Trial Optional) PAR-22-218 NCI This Funding Opportunity Announcement (FOA) solicits applications investigating the biology and underlying mechanisms of bladder cancer. Bladder cancer is a significant health problem both in the… More
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R21 Clinical Trial Optional) PAR-22-165 NCI Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) announces its interest in supporting meritorious research projects in three distinct domains related to cancer… More
Mechanistic links between diet, lipid metabolism, and tumor growth and progression (U01 Clinical Trial Not Allowed) PAR-23-051 NCI The purpose of this funding opportunity announcement is to request applications that propose mechanistic investigations of the links between diet, lipid metabolism and tumor growth and progression.… More
Mechanistic links between diet, lipid metabolism, and tumor growth and progression (UH2 Clinical Trial Not Allowed) PAR-23-052 NCI The purpose of this funding opportunity announcement is to request applications that propose mechanistic investigations of the links between diet, lipid metabolism and tumor growth and progression.… More
Co-infection and Cancer (R01 Clinical Trial Not Allowed) PAR-23-055 NCI This initiative seeks to enhance our mechanistic and epidemiologic understanding of infection-related cancers, with a focus on the etiologic roles of co-infection in cancer.
Preference will be… More
Co-infection and Cancer (R21 Clinical Trial Not Allowed) PAR-23-056 NCI The purpose of this Funding Opportunity Announcement (FOA) is to enhance mechanistic and epidemiologic investigations addressing the roles of co-infection and cancer to shed light on presently… More
Pragmatic Trials across the Cancer Control Continuum (UG3/UH3 Clinical Trial Required) PAR-22-256 NCI Through this funding opportunity announcement (FOA), the National Cancer Institute (NCI) intends to accelerate the development of evidence-based cancer-related interventions to improve health equity… More
NCI Small Grants Program for Cancer Research for Years 2023, 2024, and 2025 (NCI Omnibus) (R03 Clinical Trial Optional) PAR-23-058 NCI This funding opportunity announcement (FOA) supports small research projects on cancer that can be carried out in a short period of time with limited resources. The R03 grant mechanism supports… More
National Cancer Institute Program Project Applications for the Years 2023, 2024, and 2025 (P01 Clinical Trial Optional) PAR-23-059 NCI Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) invites applications for investigator-initiated Program Project (P01) applications. The proposed Program may… More
Global Infectious Disease Research Training Program (D43 Clinical Trial Optional) PAR-21-120 FIC This Funding Opportunity Announcement (FOA) encourages joint applications for the Global Infectious Disease (GID) Research Training programs from U.S. and low- and middle-income country (LMIC)… More
Emerging Global Leader Award (K43 Independent Clinical Trial Required) PAR-21-251 FIC This is a reissue of the Emerging Global Leader Program (K43) to align with the clinical trials policy.
Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed) PAR-21-252 FIC This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study… More
International Research Ethics Education and Curriculum Development Award (R25 Clinical Trial Not Allowed) PAR-22-118 FIC Education programs supported by this initiative will equip scientists, health professionals and academics in low and middle-income countries with in-depth knowledge of the ethical principles,… More
Chronic, Non-Communicable Diseases and Disorders Across the Lifespan: Fogarty International Research Training Award (NCD-LIFESPAN) (D43 Clinical Trial Optional) PAR-22-104 FIC This funding opportunity announcement (FOA) is a reissue due to an omission of TRAINING RECORD review questions in Section V. This FOA encourages applications for the Chronic, Non-Communicable… More
Infrastructure Development Training Programs for Critical HIV Research at Low-and Middle-Income Country Institutions (G11 Clinical Trials Not Allowed) PAR-22-153 FIC The overall goal of the Fogarty International Center (FIC) HIV Research Training Program is to strengthen the scientific capacity of institutions in low- and middle-income countries (LMICs) to… More
Fogarty HIV Research Training Program for Low-and Middle-Income Country Institutions (D43 Clinical Trial Optional) PAR-22-151 FIC The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications for research training programs to strengthen the scientific capacity of institutions in low- and middle-income… More
Global Brain and Nervous System Disorders Research Across the Lifespan (R21 Clinical Trial Optional) PAR-22-098 FIC This is a reissue to correct a few errors and omissions. This Funding Opportunity Announcement (FOA) encourages exploratory/developmental research grant applications, proposing the development of… More
Global Brain and Nervous System Disorders Research Across the Lifespan (R01 Clinical Trials Optional) PAR-22-097 FIC This is a reissue to correct errors and omissions. This Funding Opportunity Announcement (FOA) encourages grant applications for the conduct of innovative, collaborative research projects between U.S… More
Translational Centers for Microphysiological Systems (TraCe MPS) (U2C Clinical Trials Not Allowed) RFA-TR-23-001 NCATS The purpose of this funding opportunity announcement (FOA) is to establish Centers to support research that will accelerate the translational use of Microphysiological Systems (MPS) in drug… More
Emergency Awards: HEAL Initiative: Translational Science Career Enhancement Awards for Early and Mid-career Investigators (K18 Clinical Trials Not Allowed) PAR-22-058 NCATS NCATS is issuing this FOA in response to the declared public health emergency issued by the Secretary, HHS. Please see Determination that a Public Health Emergency Exists Nationwide as the Result of… More
Emergency Awards: HEAL Initiative- New Innovator Award (DP2 Clinical Trial Not Allowed) RFA-TR-22-013 NCATS NCATS is issuing this FOA in response to the declared public health emergency issued by the Secretary, HHS. Please see Determination that a Public Health Emergency Exists Nationwide as the Result of… More
Emergency Awards: HEAL Initiative-Early-Stage Discovery of New Pain and Opioid Use Disorder Targets Within the Understudied Druggable Proteome (R21 Clinical Trial Not Allowed) RFA-TR-22-011 NCATS NCATS is issuing this FOA in response to the declared public health emergency issued by the Secretary, HHS. Please see Determination that a Public Health Emergency Exists Nationwide as the Result of… More
Drug Development Collaboratory (UG3/UH3 Clinical Trial Required) PAR-20-301 NCATS The purpose of this Funding Opportunity Announcement (FOA) is to support intramural-extramural collaborations on late-stage translational science projects between NCATS Therapeutic Development Branch… More
Basket Clinical Trials of Drugs Targeting Shared Molecular Etiologies in Multiple Rare Diseases (U44 Clinical Trial Required) RFA-TR-22-029 NCATS The purpose of this Funding Opportunity Announcement (FOA) is to support basket clinical trials of drugs targeting shared molecular etiologies in more than one rare disease. To facilitate clinical… More
Botulinum Toxin Potency Assay using Tissue Chips (BoT PATCh) (U43/U44 - Clinical Trail Not Allowed) RFA-TR-22-032 NCATS This FOA provides support using the SBIR cooperative agreement mechanisms for the development, regulatory qualification and commercialization of alternative approaches methods (NAMs) that… More
Botulinum Toxin Potency Assay using Tissue Chips (BoT PATCh) (UT1, UT2 Clinical Trail Not Allowed) RFA-TR-22-031 NCATS This FOA provides support using the STTR cooperative agreement mechanisms for the development, regulatory qualification and commercialization of alternative approaches methods (NAMs) that… More
Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional) PAR-21-121 NCATS The purpose of this FOA is to enhance the capability of NCATS CTSA Program KL2 scholars and recipients of diversity and re-entry supplements supported by the CTSA Program to conduct research as they… More
Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed) RFA-TR-22-030 NCATS The purpose of this funding opportunity announcement (FOA) is to solicit applications for pilot projects to elucidate a role for understudied proteins associated with rare diseases. Awards will… More
Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science for UM1 CTSA Hub Awards (RC2 Clinical Trials Not Allowed) PAR-21-340 NCATS The purpose of the High Impact Specialized Innovation Programs (SIPs) is to support the development and demonstration of unique hub capabilities, research platforms and/or resources to address in a… More
Limited Competition: Ruth L. Kirschstein National Research Service Award (NRSA) Predoctoral Research Training Grant for the Clinical and Translational Science Awards (CTSA) Program (T32 Clinical Trial Not Allowed) PAR-21-337 NCATS The National Center for Advancing Translational Sciences (NCATS) will award Ruth L. Kirschstein National Research Service Award (NRSA) Predoctoral Institutional Research Training Grants for the… More
Clinical and Translational Science Award (UM1 Clinical Trial Optional) PAR-21-293 NCATS This funding opportunity announcement (FOA) invites applications for the Clinical and Translational Science Award (CTSA) Program hubs that will be part of a national, collaborative consortium focused… More
Limited Competition: Mentored Research Career Development Program Award in Clinical and Translational Science Awards (CTSA) Program (K12 Clinical Trial Optional) PAR-21-336 NCATS The National Center for Advancing Translational Sciences (NCATS) will award Institutional Research Career Development (K12) programs through the Clinical and Translational Science Awards (CTSA).
Limited Competition: NCATS Clinical and Translational Science Award (CTSA) Program Research Education Grants Programs (R25 - Clinical Trial Not Allowed) PAR-21-339 NCATS The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this R25 program is to support educational activities that… More
Limited Competition: Ruth L. Kirschstein National Research Service Award (NRSA) Postdoctoral Research Training Grant for the Clinical and Translational Science Awards (CTSA) Program (T32 Clinical Trial Not Allowed) PAR-21-338 NCATS The National Center for Advancing Translational Sciences (NCATS) will award Ruth L. Kirschstein National Research Service Award (NRSA) Postdoctoral Institutional Research Training Grants for the… More
Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed) PAR-22-101 NCATS This Funding Opportunity Announcement (FOA) invites researchers to submit applications for support of clinical projects that address critical needs for clinical trial readiness in rare diseases. The… More
Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R03 Clinical Trial Not Allowed) PAR-22-100 NCATS This Funding Opportunity Announcement (FOA) invites researchers to submit applications for support of clinical projects that address critical needs for clinical trial readiness in rare diseases. The… More
Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional) PAR-22-167 NCATS The Clinical and Translational Science Award (CTSA) Program Collaborative and Innovative Acceleration Award (CCIA) supports synergistic activities that accelerate the translational research process… More
Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Natural Products (Collaborative UG3/UH3 Clinical Trial Required) PAR-20-215 NCCIH This Funding Opportunity Announcement (FOA) encourages cooperative agreement applications for investigator-initiated, multi-site, clinical trials (Phase III and beyond) to study the effects of… More
Natural Product Multi-Site Clinical Trial Data Coordinating Center (Collaborative U24 Clinical Trial Required) PAR-20-219 NCCIH This Funding Opportunity Announcement (FOA), utilizing the U24 grant funding mechanism, encourages applications for a collaborating Data Coordinating Center (DCC) application that accompanies an… More
NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required) PAR-20-218 NCCIH This Funding Opportunity Announcement (FOA) encourages applications for investigator-initiated, early phase, clinical trials of natural products (i.e., botanicals, dietary supplements, and probiotics… More
Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required) PAR-20-154 NCCIH This Funding Opportunity Announcement (FOA) encourages applications for investigator-initiated fully remotely delivered and conducted clinical trials to assess the efficacy or effectiveness of… More
NCCIH Natural Product Mid Phase Clinical Trial Cooperative Agreement (U01 Clinical Trial Required) PAR-20-216 NCCIH This Funding Opportunity Announcement (FOA) invites cooperative agreement applications for investigator-initiated mid-phase clinical trials of natural products. All applications submitted under this… More
Center of Excellence for Research on Complementary and Integrative Health (P01,Clinical Trial Optional) PAR-20-138 NCCIH This Funding Opportunity Announcement (FOA) encourages the submission of applications requiring multi-project, synergistic collaborations blending multiple research approaches from outstanding… More
NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required) PAR-20-217 NCCIH This Funding Opportunity Announcement (FOA) encourages applications for investigator-initiated, early phase, clinical trials of natural products (i.e., botanicals, dietary supplements, and probiotics… More
Promoting Research on Music and Health: Phased Innovation Award for Music Interventions (R61/R33 Clinical Trial Optional) PAR-20-266 NCCIH The purpose of this Funding Opportunity Announcement (FOA) is to promote innovative research on music and health with an emphasis on developing music interventions aimed at understanding their… More
Notice of Special Interest (NOSI): Methods Development in Natural Products Research (SBIR/STTR) NOT-AT-20-015 NCCIH Notice Special Interest NOSI): Methods Development Natural Products Research SBIR/STTR) Notice Number: NOT-AT-20-015 Key Dates Release Date: July 16, 202 First Available Due Date: September 05, 2020… More
Limited Competition for the Continuation or Revision of Multisite Clinical Trial Clinical Coordinating Center (Collaborative UH3 Clinical Trial Optional) PAR-21-117 NCCIH This Funding Opportunity Announcement (FOA) encourages applications for competing renewal of Clinical Coordinating Center (CCC) for ongoing clinical trials supported by NCCIH; or competitive… More
Limited Competition for the Continuation of Multisite Clinical Trial Data Coordinating Center (Collaborative U24 Clinical Trial Optional) PAR-21-116 NCCIH This Funding Opportunity Announcement (FOA), utilizing the U24 grant funding mechanism, encourages applications for competing renewal of Data Coordinating Center (DCC) for ongoing clinical trials… More
Research Network to Promote Multidisciplinary Mechanistic and Translational Studies of Sickle Cell Disease Pain (U24, Clinical Trial Optional) RFA-AT-24-001 NCCIH The purpose of this FOA is to support a Research Network that promotes multidisciplinary mechanistic and translational studies of Sickle Cell Disease (SCD) pain. This network is expected to develop… More
Notice of Special Interest: NCCIH Administrative Supplements to NCATS CTSA Programs for Scholars Pursuing Complementary Health Research Career Development NOT-AT-20-010 NCCIH Notice Special Interest: NCCIH Administrative Supplements NCATS CTSA Programs Scholars Pursuing Complementary Health Research Career Development Notice Number: NOT-AT-20-010 Key Dates Release Date:… More
NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required) PAR-21-241 NCCIH This Funding Opportunity Announcement (FOA) invites applications for investigator-initiated clinical trials of complementary and integrative health approaches with physical and/or psychological… More
Data Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative U24 Clinical Trial Required) PAR-21-242 NCCIH This Funding Opportunity Announcement (FOA), utilizing the U24 grant funding mechanism, encourages applications for a collaborating Data Coordinating Center (DCC) application that accompanies an… More
Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required) PAR-21-240 NCCIH The goal of this funding opportunity is to support early phase clinical trials of complementary and integrative health approaches with physical and/or psychological therapeutic inputs (often called… More
Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative UG3/UH3 Clinical Trial Required) PAR-21-243 NCCIH This Funding Opportunity Announcement (FOA) encourages applications for investigator-initiated multi-site clinical trials (e.g. efficacy, effectiveness or pragmatic trials) to study the effects of… More
Notice of Special Interest (NOSI): Promoting Research on Interoception and Its Impact on Health and Disease NOT-AT-21-002 NCCIH The purpose of this NOSI is to promote innovative and rigorous research on interoception and its impact on health and disease. This initiative is broadly supported by many participating NIH… More
NEI Collaborative Clinical Vision Research : Chair's Grant (UG1-Clinical Trial Required) PAR-21-041 NEI The NEI uses UG1 cooperative agreement awards to support investigator-initiated large-scale clinical trials, human gene-transfer and stem cell therapy trials, and other complex or high resource- or… More
NEI Collaborative Clinical Vision Project: Resource Center Grant (UG1- Clinical Trial Required) PAR-21-043 NEI The NEI uses UG1 cooperative agreement awards to support investigator-initiated large-scale clinical trials, human gene-transfer and stem cell therapy trials, and other complex or high resource- or… More
NEI Collaborative Clinical Vision Research Project: Coordinating Center Grant (UG1 Clinical Trial Required) PAR-21-042 NEI The NEI uses UG1 cooperative agreement awards to support investigator-initiated large-scale clinical trials, human gene-transfer and stem cell therapy trials, and other complex or high resource- or… More
NEI Institutional Mentored Physician Scientist Award (K12 Clinical Trial Optional) PAR-21-073 NEI The purpose of this Funding Opportunity Announcement (FOA) is to encourage institutions to propose creative and innovative institutional research career development programs which prepare clinically-… More
BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed) RFA-EY-21-001 NEI A central goal of the BRAIN Initiative is to understand how electrical and chemical signals code information in neural circuits and give rise to sensations, thoughts, emotions and actions. While… More
India Collaborative Vision Research Program (R01 Clinical Trial Not Allowed) PAR-21-249 NEI This funding Opportunity Announcement (FOA) encourages Multiple Principal Investigator (Multi-PD/PI) applications from United States (U.S.) and Indian institution as bilateral collaborations that… More
BRAIN Initiative-Related Research Education: Short Courses (R25 Clinical Trial Not Allowed) RFA-EY-21-003 NEI The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this Brain Research through Advancing Innovative… More
NEI Vision Research Epidemiology Grant (UG1 Clinical Trial Not Allowed) PAR-21-204 NEI The National Eye Institute (NEI) supports investigator-initiated, complex, multi-center and other high resource risk epidemiologic studies under the cooperative agreement mechanism, UG1 activity code… More
NEI Cooperative Agreement for Early-Stage Clinical Trials with Greater than Minimal Risk (U01 Clinical Trial Required) PAR-22-149 NEI The NEI uses U01 cooperative agreement awards to support investigator-initiated early-stage clinical trials that are greater than minimal risk and typically are Phase I or II trials. The risk level… More
NEI Research Grant for Vision-Related Secondary Data Analysis (R21 Clinical Trial Not Allowed) PAR-22-141 NEI The goal of this funding opportunity announcement (FOA) is to fund meritorious vision-related research projects that involve secondary data analyses using existing database resources. The development… More
NEI Regenerative Medicine Clinical Trial Planning Grant (R34 - Clinical Trials Not Allowed) PAR-22-135 NEI The National Eye Institute (NEI) Audacious Goal Initiative (AGI) is an effort to push the boundaries of vision science and restore vision through regeneration of cells in the retina. AGI research… More
NEI Clinical Research Study Planning Grant Program (R34 Clinical Trial Not Allowed) PAR-22-128 NEI The National Eye Institute (NEI) supports large-scale clinical vision research projects, including randomized clinical trials and epidemiologic studies. At the time of submission, applications… More
Notice of Special Interest (NOSI): Clarification of the Objectives and Program Elements in NHGRI Applications Submitted in Response to the "Ruth L. Kirschstein NRSA Institutional Research Training Grants (Parent T32)" NOT-HG-21-032 NHGRI The National Human Genome Research Institute (NHGRI) is issuing this Notice to highlight interest in receiving grant applications focused in the following area(s):
1.Genome sciences to support… More
Notice of Special Interest: Genomic Data Repositories (PAR-20-089) and Knowledgebases (PAR-20-097) NOT-HG-20-017 NHGRI Notice Special Interest: Genomic Data Repositories PAR-20-089) Knowledgebases PAR-20-097) Notice Number: NOT-HG-20-017 Key Dates Release Date: February 6, 2020 First Available Due Date: 25, 2020… More
Mentored Research Experiences for Genetic Counselors (R25) PAR-21-074 NHGRI The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this NHGRI R25 program is to support educational activities… More
Research Experiences in Genomic Research for Data Scientists (R25) PAR-21-075 NHGRI The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this NHGRI R25 program is to support research experiences in… More
Genomic Community Resources (U24 Clinical Trial Not Allowed) PAR-20-100 NHGRI To facilitate genomic research and the dissemination of its products, NHGRI supports genomic resources that are crucial for basic research, disease studies, model organism studies, and other… More
Entry-Level Modules (ELM) for Training the Genomics Research Workforce (R25-Clinical Trial Not Allowed) PAR-23-123 NHGRI The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this R25 program is to support educational activities that… More
Technology Development for Single-Molecule Protein Sequencing (R43/R44 Clinical Trial not allowed) PAR-21-247 NHGRI This Funding Opportunity Announcement (FOA) solicits grant applications to catalyze major advances in single-molecule protein sequencing through technology development. The goal of this initiative is… More
Genome Research Experiences to Attract Talented Undergraduates into Genomic Fields to Enhance Diversity (R25 Clinical Trial Not Allowed) RFA-HG-22-004 NHGRI The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this NHGRI R25 program is to support educational activities… More
Genome Research Experiences to Attract Talented Undergraduates into the Genomics Field to Enhance Diversity (R25 Clinical Trial Not Allowed) RFA-HG-21-033 NHGRI The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this NHGRI R25 program is to support educational activities… More
Center for Inherited Disease Research (CIDR) High Throughput Sequencing and Genotyping Resource Access (X01) PAR-20-230 NHGRI The Center for Inherited Disease Research (CIDR) high-throughput genotyping, sequencing and supporting statistical genetics services are designed to aid the identification of genes or genetic… More
Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21) (Clinical Trial Optional) PAR-20-255 NHGRI This Funding Opportunity Announcement (FOA) invites Exploratory/Developmental Research Grant (R21) applications that propose to study the ethical, legal and social implications (ELSI) of human genome… More
Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03) Clinical Trial Optional) PAR-20-257 NHGRI This Funding Opportunity Announcement (FOA) invites Small Research Grant (R03) applications to study the ethical, legal and social implications (ELSI) of human genome research. These applications… More
Ethical, Legal and Social Implications (ELSI) (Research R01 Clinical Trial Optional) PAR-20-254 NHGRI This Funding Opportunity Announcement (FOA) invites Research Project Grant (R01) applications that propose to study the ethical, legal and social implications (ELSI) of human genome research.… More
Notice of Special Interest: Development of Statistical, Population Genetics and Computational Methods Related to Polygenic Prediction of Health and Disease in Diverse Populations NOT-HG-20-010 NHGRI Notice Special Interest: Development Statistical, Population Genetics Computational Methods Related Polygenic Prediction Health Disease Diverse Populations Notice Number: NOT-HG-20-010 Key Dates… More
Genomic Curriculum Development for Medical Students (R25 Clinical Trial Not Allowed) PAR-21-312 NHGRI The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this NHGRI R25 program is to support educational activities… More
New Investigators to Promote Workforce Diversity in Genomics, Bioinformatics, or Bioengineering and Biomedical Imaging Research (R01 Clinical Trial Optional) RFA-HG-21-041 NHGRI This Funding Opportunity Announcement (FOA) solicits R01 grant applications that propose independent research projects that are within the scientific mission areas of the National Human Genome… More
Supporting Talented Early Career Researchers in Genomics (R01 Clinical Trial Optional) RFA-HG-22-001 NHGRI This Funding Opportunity Announcement is intended to identify and support research projects by exceptionally promising Early Stage Investigators with a long-term career interest in pursuing… More
NHGRI Predoctoral to Postdoctoral Transition Award for a Diverse Genomics Workforce (F99/K00) PAR-21-143 NHGRI The purpose of the NHGRI Predoctoral to Postdoctoral Transition Award for a Diverse Genomics Workforce (F99/K00) is to support a defined pathway across career stages for talented graduate students… More
Diversity Centers for Genome Research (U54 Clinical Trials Optional) RFA-HG-22-026 NHGRI The Diversity Center for Genome Research (DCGR) program aims to establish Genomic Research Centers at Minority Serving Institutions (MSIs) as defined in Part 2, section III of the FOA. The MSIs must… More
Diversity Centers for Genome Research (UG3/UH3 Clinical Trials Optional) RFA-HG-22-027 NHGRI Funding Opportunity PurposeThe full-scale Diversity Centers for Genome Research (DCGR) program aims to establish Genomic Research Centers at Minority Serving Institutions (MSIs) as defined in Part 2… More
Investigator Initiated Research in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed) PAR-21-254 NHGRI The purpose of this funding opportunity announcement (FOA) is to invite applications for a broad range of research efforts in computational genomics, data science, statistics, and bioinformatics… More
Investigator Initiated Research in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed) PAR-21-255 NHGRI The purpose of this funding opportunity announcement (FOA) is to invite applications for a broad range of research efforts in computational genomics, data science, statistics, and bioinformatics… More
Notice of Special Interest (NOSI): Methods Development for Genomic Studies of Genetic Variation, Function, and Disease NOT-HG-22-007 NHGRI The National Human Genome Research Institute (NHGRI) is issuing this Notice of Special Interest (NOSI) to encourage applications that develop novel computational or experimental approaches for… More
NHGRI Short Courses for Genomics-Related Research Education (R25 Clinical Trial Not Allowed) PAR-22-095 NHGRI The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NHGRI R25 program is to support educational activities… More
Notice of Special Interest: Development and Implementation of Clinical Informatics Tools to Enhance Patients Use of Genomic Information NOT-HG-22-011 NHGRI The National Human Genome Research Institute (NHGRI) is issuing a Notice of Special Interest (NOSI) to encourage applications to develop and implement patient-facing genomic-based clinical… More
RESCINDED - Notice of Special Interest (NOSI): Integrative Omics Analysis of NHLBI TOPMed Data (Parent R01 Clinical Trial Not Allowed) NOT-HL-21-007 NHLBI The symptom-based diagnosis and treatment of heart, lung, blood, and sleep (HLBS) diseases has vastly improved in recent years, yet an understanding of the molecular mechanisms underlying many of… More
Pediatric Heart Network Clinical Research Centers (UM1 Clinical Trial Optional) RFA-HL-24-001 NHLBI The purpose of this FOA is to invite applications to participate as a Clinical Research Center (CRC) in the Pediatric Heart Network (https://www.pediatricheartnetwork.org/). CRCs will be expected to… More
Limited Competition: Pediatric Heart Network for the Data Coordinating Center (U24 Clinical Trial Not Allowed) RFA-HL-24-002 NHLBI This limited competition Funding Opportunity Announcement (FOA)is to support the Data Coordinating Center (DCC) for the Pediatric Heart Network (https://www.pediatricheartnetwork.org/). Only the… More
Notice of Special Interest (NOSI): Pulmonary Complications of Hematopoietic Stem Cell Transplantation in Childhood NOT-HL-20-761 NHLBI Notice Special Interest NOSI): Pulmonary Complications Hematopoietic Stem Cell Transplantation Childhood Notice Number: NOT-HL-20-761 Key Dates Release Date: April 27, 2020 First Available Due Date… More
NHLBI Program Project Applications (P01 Clinical Trials Optional) PAR-21-088 NHLBI The National Heart, Lung, and Blood Institute (NHLBI) Program Project Grant (P01) supports research related to fundamental processes and diseases of the heart, blood and lymphatic vessels, lungs, and… More
Notice of Special Interest (NOSI): Use of Predictive Analytics to Accelerate Late-Stage Implementation Research to Address Heart, Lung, Blood, and Sleep Disorders NOT-HL-20-815 NHLBI NHLBI is issuing this Notice of Special Interest (NOSI) to leverage existing data resources using Predictive Analytics Implementation Research (PAIR) that utilizes complex and innovative… More
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics (R33 Clinical Trial Required) PAR-21-118 NHLBI The objective of this funding opportunity is to support investigator-initiated, phase I clinical trials for diagnostic and therapeutic interventions for heart, lung, blood, and sleep (HLBS) disorders… More
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics (R61/R33 Clinical Trial Required) PAR-21-119 NHLBI The objective of this funding opportunity is to support investigator-initiated, Phase I clinical trials for diagnostic and therapeutic interventions for heart, lung, blood, and sleep (HLBS) disorders… More
NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional) PAR-21-079 NHLBI Reissue of PAR-19-155
Short-Term Research Education Program to Enhance Diversity in Health-Related Research (R25 Clinical Trial Not Allowed) RFA-HL-22-012 NHLBI The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NHLBI R25 program is to support educational activities… More
NHLBI SBIR Phase IIB Small Market Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional) RFA-HL-23-008 NHLBI The Small Business Innovation Research (SBIR) Program is an important National Institutes of Health (NIH) funding mechanism used to develop innovative solutions that address public health challenges… More
NHLBI SBIR Phase IIB Bridge Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional) RFA-HL-23-009 NHLBI The Small Business Innovation Research (SBIR) Program is an important funding mechanism that the National Institutes of Health (NIH) uses to develop innovative solutions that address public health… More
T32 Training Program for Institutions That Promote Diversity (T32 Clinical Trial Not Allowed) RFA-HL-22-001 NHLBI The purpose of this funding opportunity announcement (FOA) is to enhance the participation of individuals from nationally underrepresented backgrounds in cardiovascular, pulmonary, hematologic and… More
Physician Scientist Transition to Independence in Blood Science Research (R00 - Clinical Trial Optional) RFA-HL-23-003 NHLBI The purpose of this limited competition R00 program is to provide physician scientists in blood science with a seamless pathway from a mentored K99/R00 award to investigator independence. Eligible… More
NHLBI Outstanding Investigator Award (OIA) (R35 Clinical Trial Optional) RFA-HL-23-004 NHLBI The purpose of the NHLBI Outstanding Investigator Award (OIA) is to promote scientific productivity and innovation by providing long-term support and increased flexibility to experienced Program… More
NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional) RFA-HL-23-005 NHLBI The purpose of the NHLBI Emerging Investigator Award (EIA) is to promote scientific productivity and innovation by providing long-term support and increased flexibility to experienced Program… More
Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01 Independent Clinical Trial Required) RFA-HL-22-010 NHLBI This Funding Opportunity Announcement (FOA) invites applications to enhance the pool of highly trained investigators from diverse backgrounds, including those from groups underrepresented in research… More
Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01 Independent Clinical Trial Not Allowed) RFA-HL-22-011 NHLBI This Funding Opportunity Announcement (FOA) invites applications to enhance the pool of of highly trained investigators from diverse backgrounds , including those from groups underrepresented in… More
Stimulating Access to Research in Residency (StARR) (R38) RFA-HL-23-006 NHLBI The purpose of this program is to recruit and retain outstanding, postdoctoral-level health professionals who have demonstrated potential and interest in pursuing careers as clinician-investigators.… More
NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Independent Clinical Trial Not Allowed) PAR-22-034 NHLBI The purpose of the NHLBI Career Transition Award (K22) program is to provide highly qualified postdoctoral fellows and other doctoral-level researchers still in training in the NHLBI Division of… More
NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Clinical Trial Required) PAR-22-040 NHLBI The purpose of the NHLBI Career Transition Award (K22) program is to provide highly qualified postdoctoral fellows in the NHLBI Division of Intramural Research the opportunity to transition their… More
NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed) PAR-22-194 NHLBI This Funding Opportunity Announcement (FOA) invites applications to use the NHLBI-funded TransOmics for Precision Medicine (TOPMed) program to generate a large volume of integrated genetic and multi-… More
Maximizing the Scientific Value of the NHLBI Biologic Biospecimen Repository: Scientific Opportunities for Exploratory Research (R21) RFA-HL-23-018 NHLBI This Funding Opportunity Announcement (FOA) will support meritorious exploratory research relevant to the NHLBI mission (http://www.nhlbi.nih.gov/about/org/mission) using the existing biospecimen… More
Catalyze: Product Definition Device Prototype Testing and Design Modification, Diagnostic Disease Target Assay Development and Design Characterization, and Research Tool Testing and Validation (R33 - Clinical Trials Not Allowed) RFA-HL-23-014 NHLBI This Funding Opportunity Announcement (FOA) will provide the early stage translational support needed for prototype testing/design modification, assay development for diagnostic disease targets, and… More
Catalyze: Product Definition for Small Molecules and Biologics - Preliminary Product/Lead Series Identification (R33 - Clinical Trial Not Allowed) RFA-HL-23-012 NHLBI This Funding Opportunity Announcement (FOA) will provide the early stage translational support needed to identify a lead compound series toward development of potential therapeutic agents to treat… More
Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed) RFA-HL-23-010 NHLBI This Funding Opportunity Announcement (FOA) solicits grant applications to further develop enabling technologies and transformative platforms to catalyze next-generation predictive, diagnostic and… More
Catalyze: Product Definition Device Prototype Design and Testing, Diagnostic Disease Target Identification and Assay Development, and Research Tool Development (R61/R33 - Clinical Trial Not Allowed) RFA-HL-23-013 NHLBI This Catalyze Product Definition Funding Opportunity Announcement (FOA) will provide the early stage translational support needed to develop and test device prototype designs, identify diagnostic… More
Catalyze: Product Definition for Small Molecules and Biologics - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed) RFA-HL-23-011 NHLBI This Catalyze Product Definition Funding Opportunity Announcement (FOA) will provide the early stage translational support needed to identify and characterize potential therapeutic candidates to… More
Notice of Special Interest (NOSI): IDEA2Health: Innovative Data Evaluation and Analysis to Health NOT-HL-22-001 NHLBI The purpose of this Notice of Special Interest (NOSI) is to inform applicants to the National Heart, Lung, and Blood Institute (NHLBI) of an area of special interest in the development and… More
Limited Competition: Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38 Clinical Trial Not Allowed) RFA-HL-23-007 NHLBI The purpose of this program is to provide continued support to Transition Scholars who have successfully matriculated through the NIH Stimulating Access to Research in Residency (StARR) R38 program… More
Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required) PAR-22-193 NHLBI This Funding Opportunity Announcement (FOA) supports applications for a collaborating Data Coordinating Center (DCC) for investigator-initiated multi-site clinical trials including efficacy,… More
Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required) PAR-22-189 NHLBI This Funding Opportunity Announcement (FOA) supports applications to develop and implement investigator-initiated single site clinical trials including efficacy, comparative effectiveness, pragmatic… More
Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required) PAR-22-192 NHLBI This Funding Opportunity Announcement (FOA) supports applications to develop and implement a Clinical Coordinating Center (CCC) for investigator-initiated multi-site clinical trials including… More
Limited Competition: Small Grant Program for NHLBI K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional) RFA-HL-24-005 NHLBI The purpose of this funding opportunity announcement (FOA) is to solicit current or recently completed NHLBI K01, K08, K23, and K25 awardees for small grant support to expand their current research… More
Secondary Analysis of Existing Datasets in Heart, Lung, and Blood Diseases and Sleep Disorders (R21 Clinical Trial Not Allowed) PAR-23-036 NHLBI The goal of this funding opportunity is to stimulate the use of existing human datasets for well-focused secondary analyses to investigate novel scientific ideas or new models, systems, tools,… More
Notice of Special Interest (NOSI): Integrative Omics Analysis of NHLBI TOPMed Data (Parent R01 Clinical Trial Not Allowed) NOT-HL-23-067 NHLBI The symptom-based diagnosis and treatment of heart, lung, blood, and sleep (HLBS) diseases has vastly improved in recent years, yet an understanding of the molecular mechanisms underlying many of… More
Notice of Special Interest (NOSI): Development of Functional Assay Sites to Evaluate Candidate -Omics Variants Associated with Heart, Lung, Blood, or Sleep Disease (R01, R41, R42, R43, R44) NOT-HL-23-066 NHLBI Large-scale high-throughput sequencing studies, such as the NHLBIs Trans-Omics for Precision Medicine (TOPMed) program and the NHGRIs Genome Sequencing Program, have identified hundreds of millions… More
Notice of Special Interest (NOSI): Understanding Sudden Death in the Young Through Research NOT-HL-22-040 NHLBI This Notice of Special Interest (NOSI) highlights interest in receiving grant applications focused on mechanistic, genetic, and other studies to evaluate causes and consequences of and risk factors… More
Translational Bioinformatics Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease (R01 Clinical Trial Optional) PAR-20-156 NIA This Funding Opportunity Announcement (FOA) enables data-driven drug repositioning and combination therapy for Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD) by… More
NIA MSTEM: Advancing Diversity in Aging Research through Undergraduate Education (R25 - Independent Clinical Trial Not Allowed) PAR-20-317 NIA The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this R25 program is to support educational activities that… More
Interorgan Communication in Aging (U01 Clinical Trial Not Allowed) RFA-AG-24-005 NIA The goal of this RFA is to foster research that examines the molecular mechanisms and consequences of age-related alterations in interorgan communication, thereby modulating the age-related decline… More
Interventions Testing Program (ITP) Data Coordinating Center (U24 Clinical Trial Not Allowed) RFA-AG-24-003 NIA This Funding Opportunity Announcement (FOA) invitesapplications utilizing a cooperative agreement (U24) mechanism to implement a Data Coordinating Center (DCC) that will provide data storage,… More
Renewal of the Interventions Testing Program (U01 Clinical Trial Not Allowed) RFA-AG-24-002 NIA This FOA is for the renewal and further development of the Interventions Testing Program (ITP). The ITP tests, under standardized conditions, potential intervention strategies which may delay aging… More
Roybal Centers for Translational Behavioral Research on Dementia Care, Caregiver Support, and Prevention of Alzheimers Disease and Related Dementias (AD/ADRD) (P30 Clinical Trial Required) RFA-AG-24-007 NIA This Funding Opportunity Announcement (FOA) solicits Edward R. Roybal Centers for translational intervention development research for Alzheimers Disease and Alzheimers Disease related dementias care… More
Edward R. Roybal Coordinating Center (R24 - Clinical Trial Not Allowed) RFA-AG-24-008 NIA This FOA invites applications from qualified institutions to create a Roybal Center Coordinating Center (CC), serving the needs of the Roybal Centers for Translational Research on Aging program as… More
Roybal Centers for Translational Research on Aging (P30 Clinical Trial Required) RFA-AG-24-006 NIA This Funding Opportunity Announcement (FOA) solicits Edward R. Roybal Centers for Translation Research in the Behavioral and Social Sciences of Aging. The purpose of the Roybal Centers is to develop… More
Limited Competition: The Health and Retirement Study and Harmonized Cognitive Assessment Protocol (U01 Clinical Trial Not Allowed) RFA-AG-24-010 NIA The purpose of this limited competition FOA is to solicit an application to continue data collection, development, and dissemination of the Health and Retirement Study (HRS). The HRS is a… More
Estimating the Monetary Costs of Dementia in the United States (U01 Clinical Trial Not Allowed) RFA-AG-24-004 NIA This funding opportunity announcement (FOA) invites U01 applications to develop national cost of illness estimates for the monetary cost of Alzheimers Disease and Alzheimers disease-related dementias… More
Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) Real-World Data Platform (U54 Clinical Trial Optional) RFA-AG-24-009 NIA This Funding Opportunity Announcement (FOA) invites applications for the Alzheimers Disease (AD) and Alzheimers Disease-Related Dementias (ADRD) Real-World Data (RWD) Platform initiative. This… More
Notice to Extend the Expiration Date of PAR-20-156 "Translational Bioinformatics Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease (R01 Clinical Trial Optional)" NOT-AG-22-051 NIA This Notice informs potential applicants that the expiration date for Funding Opportunity Announcement (FOA)PAR-20-156 "Translational Bioinformatics Approaches to Advance Drug Repositioning and… More
Notice of Special Interest (NOSI): Maximizing the Scientific Value of Secondary Analyses of Existing Cohorts and Datasets in Order to Address Research Gaps and Foster Additional Opportunities in Aging Research NOT-AG-21-020 NIA The goal of this Notice of Special Interest (NOSI) is to stimulate the use of existing cohorts and datasets for well-focused secondary analyses to investigate novel scientific ideas and/or address… More
AD/ADRD Clinical Trials Short Course (R25 Independent Clinical Trial Not Allowed) PAR-21-141 NIA It is essential to expand and diversify the skilled AD/ADRD clinical trial workforce. The intent of this Funding Opportunity Announcement (FOA) is to encourage applications that develop creative and… More
Team Science Approaches Integrating Experimental and Computational Brain Aging Models (R21/R33 Clinical Trial Not Allowed) RFA-AG-24-018 NIA This FOA invites applications proposing to establish new, or significantly expand existing, interdisciplinary collaborations involving both experimental and computational researchers to… More
Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (T32) PAR-21-112 NIA The specific purpose of this Funding Opportunity Announcement (FOA) is to promote the development of a diverse, interdisciplinary workforce needed to conduct translational research on Alzheimer'… More
Networking/Infrastructure Project for Research on Determinants of Differences Among Human and Nonhuman Primate Species in Life Spans, Life Histories, and Other Aging Related Outcomes, and Prospects for Translation (R61/R33 Clinical Trial Not Allowed) RFA-AG-24-020 NIA The purpose of this Funding Opportunity Announcement (FOA) is to invite R61/R33 applications proposing to establish and conduct a networking and infrastructure project to enhance the development of… More
Comparative Research on Determinants of Differences Among Human and Nonhuman Primate Species in Life Spans, Life Histories, and Other Aging-Related Outcomes, and Prospects for Translation (R01 Clinical Trial Not Allowed) RFA-AG-24-019 NIA The goal of this Funding Opportunity Announcement (FOA) is to invite R01 applications proposing comparative studies of human and nonhuman primate species with differing life spans to identify factors… More
Research Coordinating Center on the Exposome and Alzheimer's Disease (AD) and AD-Related Dementias (ADRD): Elucidating the Role of Social and Behavioral Determinants of Health in AD/ADRD Etiology and Disparities (U24 Clinical Trial Not Allowed) RFA-AG-24-011 NIA The purpose of this Funding Opportunity Announcement (FOA) is to invite applications to establish a coordinating center that will serve as a centralized hub for accessing, harmonizing, linking, and… More
Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional) PAR-21-069 NIA This FOA encourages applications at the intersection of HIV and aging by addressing two overarching objectives: 1) to improve understanding of biological, clinical, and socio-behavioral aspects of… More
Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional) PAR-21-068 NIA This FOA encourages applications at the intersection of HIV and aging by addressing two overarching objectives: 1) to improve understanding of biological, clinical, and socio-behavioral aspects of… More
Dementia Care and Caregiver Support Intervention Research (R01 Clinical Trial Required) PAR-21-307 NIA This Funding Opportunity Announcement (FOA) solicits mechanism-focused dementia care and caregiver support intervention development research at Stages I through V of the NIH Stage Model to address… More
Pragmatic Trials for Dementia Care and Caregiver Support (R61/R33 Clinical Trial Required) PAR-21-308 NIA This Funding Opportunity Announcement(FOA) will support pragmatic trials within Stage IV of the NIH Stage Model to improve dementia care across multiple dementia care settings that will: (1) be… More
NIA Advanced Postdoctoral Career Transition Awards to Promote Diversity in Translational Research for AD/ADRD (K99/R00 Clinical Trial Not Allowed) PAR-21-220 NIA The purpose of this Funding Opportunity Announcement (FOA) is to diversify the translational research workforce for Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD).… More
NIA Academic Leadership Career Award (K07 Independent Clinical Trial Not Allowed) PAR-21-106 NIA The objective of the NIA Academic Leadership Career Award (K07) is to provide support for senior investigators who have the expertise and leadership skills to enhance aging and geriatric research… More
Alzheimer's Clinical Trials Consortium (ACTC) Clinical Trials (R01 Clinical Trial Required) PAR-20-309 NIA This Funding Opportunity Announcement (FOA) invites applications to develop and implement Phase Ib to III clinical trials of promising pharmacological and non-pharmacological interventions that may… More
Limited Competition: Alzheimers Disease Sequencing Project Follow-Up Study 2.0 (ADSP FUS 2.0): The Diverse Population Initiative (U01 Clinical Trial Not Allowed) PAR-21-212 NIA This Funding Opportunity Announcement (FOA) invites applications specific to sample acquisition, genome wide association studies, whole genome sequencing, quality control checking, variant calling,… More
Early Stage Investigator Research Using Nonhuman Primate (NHP) Models (R21 Clinical Trial Not Allowed) PAR-21-109 NIA The purpose of this funding opportunity announcement is to provide tailored support for early stage investigators (ESIs) to initiate basic or translational research with nonhuman primates (NHPs).… More
NIA Expanding Research in AD/ADRD (ERA) Summer Research Education Program (R25 - Independent Clinical Trial Not Allowed) RFA-AG-24-013 NIA It is essential to expand and diversify the skilled Alzheimer's Disease (AD) and Alzheimers Disease Related Dementias (ADRD) research workforce and provide exposure to AD/ADRD research to… More
NIA Expanding Research in AD/ADRD (ERA) Postbaccalaureate Research Education Program (R25 - Independent Clinical Trial Not Allowed) RFA-AG-24-012 NIA It is essential to expand and diversify the skilled Alzheimers Disease and Alzheimers Disease and Related Dementias (AD/ADRD) research workforce and provide exposure to AD/ADRD research to… More
NIA Predoctoral Fellowship Award to Promote Diversity in Translational Research for AD/ADRD (F31) PAR-21-218 NIA The purpose of this Funding Opportunity Announcement (FOA) is to diversify the translational research workforce for Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD).… More
NIA Postdoctoral Fellowship Award to Promote Diversity in Translational Research for AD/ADRD (F32 Clinical Trial Not Allowed) PAR-21-217 NIA The purpose of this Funding Opportunity Announcement (FOA) is to diversify the translational research workforce for Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD).… More
NIA Renewal and Revision Cooperative Agreements in AD/ADRD Research (U24 Clinical Trial Not Allowed) PAR-22-110 NIA This Funding Opportunity Announcement (FOA) allows for renewal and competitive revision applications, and their resubmissions, for funded U24?Research Resource/Infrastructure?applications?that?… More
NIA Renewal and Competing Revision Cooperative Agreements in Aging Research (U01 Clinical Trial Optional) PAR-22-362 NIA This Funding Opportunity Announcement (FOA) allows for renewal and competing revision applications, and their resubmissions, for awarded U01 research project cooperative agreements focused on aging… More
NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurship Enhancement Award (R25 Independent Clinical Trial Not Allowed) PAR-22-226 NIA The purpose of the Research and Entrepreneurial Development Immersion (REDI): NIA Entrepreneurship Enhancement Award (R25) is to promote the development of entrepreneurial training programs that are… More
NIA Renewal and Revision Cooperative Agreements in AD/ADRD Research (U54 Clinical Trial Optional) PAR-22-077 NIA This Funding Opportunity Announcement (FOA) allows for renewal and competing revision applications, and their resubmissions, for funded U54Specialized Centercooperative agreements thatsupportlarge-… More
NIA Research and Entrepreneurial Development Immersion (REDI): Mentored Entrepreneurial Career Development Award (K01 Clinical Trial Not Allowed) PAR-22-227 NIA The purpose of the NIA Research and Entrepreneurial Development Immersion (REDI): Mentored Entrepreneurial Career Development Award is to provide support and protected time (three to five years) for… More
Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Independent Clinical Trial Not Allowed) RFA-AG-24-014 NIA This Funding Opportunity Announcement (FOA) invites early-stage physicians and other health professional investigators with a commitment to aging and/or aging-related diseases to apply for this award… More
Transition to Aging Research for Predoctoral Students (F99/K00 Clinical Trial Not Allowed) RFA-AG-23-016 NIA The National Institute on Aging (NIA) invites outstanding graduate students from a wide range of broad research areas who are interested in receiving aging-related postdoctoral training to apply to… More
Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Clinical Trial Required) RFA-AG-24-015 NIA This Funding Opportunity Announcement (FOA) invites early-stage physician and other health professional investigators with a commitment to aging and/or aging-related diseases to apply for this award… More
Alzheimer's Drug-Development Program (U01 Clinical Trial Optional) PAR-22-047 NIA The goal of this Funding Opportunity Announcement (FOA) is to provide funding support for the pre-clinical and early stage clinical (Phase I) development of novel small-molecule and biologic drug… More
Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional) PAR-22-093 NIA The purpose of this Funding Opportunity Announcement (FOA) is to invite applications proposing research on current topics in Alzheimer's disease (AD) and its related dementias (ADRD). Further… More
Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Optional) PAR-22-094 NIA The purpose of this Funding Opportunity Announcement (FOA) is to invite applications proposing new tests, animal models, techniques, etc. to advance research on Alzheimer's disease (AD) and its… More
Pilot Studies for the Spectrum of Alzheimers Disease/Alzheimers Disease-Related Dementias and Age-Related Cognitive Decline (R61 Clinical Trial Optional) PAR-23-083 NIA The purpose of this Funding Opportunity Announcement (FOA) is to 1) invite research grant applications that enable the collection of pilot data to support early stage testing of promising… More
Early and Late Stage Clinical Trials for the Spectrum of Alzheimers Disease/Alzheimers Related Dementias and Age-Related Cognitive Decline (R01 Clinical Trial Optional) PAR-23-081 NIA The purpose of this Funding Opportunity Announcement (FOA) is to 1) invite applications that propose to develop and implement early to late stage clinical trials of promising pharmacological and non-… More
NIA Career Transition Award (K22 Independent Clinical Trial Not Allowed) PAR-21-351 NIA The purpose of the NIA Career Transition Award (CTA) is to facilitate the transition of mentored researchers to tenure-track faculty conducting research that advances the mission of NIA. This three-… More
Integrative Research to Understand the Impact of Sex Differences on the Molecular Determinants of AD Risk and Responsiveness to Treatment (U01 Clinical Trial Optional) PAR-23-082 NIA This Funding Opportunity Announcement (FOA) invites applications that employ integrative experimental and analytical approaches engaging basic and translational/clinical research aimed at developing… More
Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional) PAS-22-197 NIA This Funding Opportunity Announcement (FOA) invites applications to the National Institute on Aging's (NIA) Small Business Technology Transfer Research (STTR) program. The aim of this FOA is to… More
Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional) PAS-22-196 NIA This Funding Opportunity Announcement (FOA) invites applications to the National Institute on Aging's (NIA) Small Business Innovation Research (SBIR) program. The aim of this FOA is to support… More
NIA Program Project Applications (P01 Clinical Trial Optional) PAR-22-130 NIA The National Institute on Aging (NIA) invites the submission of investigator-initiated research program project (P01) applications addressing scientific areas relevant to NIA's mission. Each… More
Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional) PAR-22-213 NIA This FOA allows for applications that propose large-scale, complex research projects with multiple highly integrated components focused on a common research question relevant to aging. Such projects… More
Alzheimer's Disease Research Centers (P30 Clinical Trial Not Allowed) RFA-AG-24-001 NIA This Funding Opportunity Announcement (FOA) invites applications from institutions proposing to develop, or renew, an Alzheimer's Disease Research Center (ADRC). The National Institute on Aging… More
Research Infrastructure Development for Interdisciplinary Aging Studies (R61/R33 - Clinical Trial Optional) PAR-23-053 NIA This FOA invites applications that propose to develop novel research infrastructure that will advance the science of aging in specific areas requiring interdisciplinary partnerships or collaborations… More
Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 Clinical Trial Optional) PAR-23-054 NIA This FOA invites applications that propose to develop novel research infrastructure that will advance the science of aging in specific areas requiring interdisciplinary partnerships or collaborations…
NIA Multi-site Clinical Trial Implementation Grant (R01 Clinical Trial Required) PAR-23-057 NIA This Funding Opportunity Announcement (FOA) invites applications for implementation of investigator-initiated multi-site interventional clinical trials (all phases). The trials should be hypothesis-… More
Alcohol Treatment and Recovery Research (R34 Clinical Trial Required) PAR-22-159 NIAAA The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R34 Clinical Trial Required mechanism focusing on alcohol treatment and recovery research. This FOA will focus… More
Alcohol Health Services Research (R01 Clinical Trial Optional) PAR-22-156 NIAAA The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R01 Clinical Trial Optional mechanism focusing on alcohol health services. This FOA will broadly focus on closing… More
Alcohol Treatment and Recovery Research (R01 Clinical Trial Required) PAR-22-158 NIAAA The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R01 Clinical Trial Required mechanism focusing on alcohol treatment and recovery research. This FOA will focus… More
Alcohol Health Services Research (R34 Clinical Trial Optional) PAR-22-157 NIAAA The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R34 Clinical Trial Optional mechanism focusing on alcohol health services. This FOA will broadly focus on closing… More
Notice of Special Interest: Secondary Analyses of Existing Alcohol Research Data NOT-AA-20-018 NIAAA Notice Special Interest: Secondary Analyses Existing Alcohol Research Data Notice Number: NOT-AA-20-018 Key Dates Release Date: August 10, 2020 First Available Due Date: October 05, 2020 Expiration… More
NIAAA Resource-Related Research Projects (R24 Clinical Trial Not Allowed) PAR-21-072 NIAAA The purpose of the Resource-Related Research Projects (R24) grant is to support investigator-initiated resources designed to provide materials and services to support and advance biomedical research… More
Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional) PAR-21-098 NIAAA This Funding Opportunity Announcement (FOA) focuses on prevention and intervention strategies for fetal alcohol spectrum disorders (FASD) throughout the lifespan. The intent of this FOA is to support… More
Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional) PAR-21-097 NIAAA This Funding Opportunity Announcement (FOA) for R34 planning grant applications focuses on prevention and intervention strategies for fetal alcohol spectrum disorders (FASD) throughout the lifespan.… More
Notice of Special Interest: Genetics of Alcohol Sensitivity and Tolerance NOT-AA-21-029 NIAAA The purpose of this notice of special interest (NOSI) is to provide enhanced understanding of genetic, genomic, and epigenetic factors contributing to biological processes for individual variation in… More
Mechanisms of Alcohol Tolerance (R21/R33 Clinical Trial Optional) PAR-21-250 NIAAA This funding opportunity announcement (FOA) focuses on sensitivity and tolerance mechanisms underlying the development of alcohol use disorder. The intent of this FOA is to: (1) develop hypotheses… More
Investigational New Drug (IND)-enabling and Early-Stage Development of Medications to Treat Alcohol Use disorder and Alcohol-Associated Organ Damage (UT1/UT2 Clinical Trial Optional) PAR-22-103 NIAAA This Funding Opportunity Announcement (FOA) supports Small Business Technology Transfer (STTR) applications from small business concerns (SBCs) that propose the development of therapeutic agents for… More
Investigational New Drug (IND)-enabling and Early-Stage Development of Medications to Treat Alcohol Use disorder and Alcohol-Associated Organ Damage (U43/U44 Clinical Trial Optional) PAR-22-102 NIAAA This Funding Opportunity Announcement (FOA) supports Small Business Innovation Research (SBIR) applications from small business concerns (SBCs) that propose the development of therapeutic agents for… More
Cooperative Centers on Human Immunology (U19 Clinical Trial Optional) RFA-AI-22-069 NIAID This Funding Opportunity Announcement (FOA) seeks to solicit applications from interdisciplinary teams to participate in the Cooperative Centers on Human Immunology (CCHI) program. The program… More
International Centers of Excellence for Malaria Research (U19 Clinical Trial Not Allowed) RFA-AI-22-067 NIAID This Funding opportunity Announcement (FOA) solicits applications for the International Centers of Excellence for Malaria Research (ICEMR) Program, a multidisciplinary network of centers that will… More
Notice of Special Interest (NOSI): NIAID Priorities for Biomedical Knowledgebases & Repositories NOT-AI-20-044 NIAID Notice Special Interest NOSI): NIAID Priorities Biomedical Knowledgebases & Repositories Notice Number: NOT-AI-20-044 Key Dates Release Date: June 8, 2020 First Available Due Date: September 25… More
NIAID Clinical Trial Planning Grant (R34 Clinical Trials Not Allowed) PAR-20-270 NIAID This Funding Opportunity Announcement (FOA) encourages applications that propose to complete planning, design, and preparation of the documentation necessary for implementation of investigator-… More
Autoimmunity Centers of Excellence, Clinical Research Program (UM1 Clinical Trial Required) RFA-AI-22-071 NIAID The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications to participate in the NIAID Autoimmunity Centers of Excellence (ACE), a cooperative network intended to improve… More
Autoimmunity Centers of Excellence, Basic Research Program (U19 Clinical Trial Not Allowed) RFA-AI-22-070 NIAID The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications to participate in the NIAID Autoimmunity Centers of Excellence (ACE), a cooperative network intended to improve… More
Genomics Centers for Infectious Diseases (U19 Clinical Trial Not Allowed) RFA-AI-23-015 NIAID The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for a Genomic Centers for Infectious Disease (GCID) Program. This renewal initiative will support GCIDs to… More
Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Centers for Flaviviridae and Togaviridae (U19 Clinical Trial Not Allowed) RFA-AI-23-019 NIAID This Funding Opportunity Announcement (FOA) solicits applications from single institutions or consortia of institutions to participate in the Research and Development of Vaccines and Monoclonal… More
Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Network - Coordination and Data Sharing Center (CDSC) (UG3/UH3 Clinical Trial Not Allowed) RFA-AI-23-021 NIAID This Funding Opportunity Announcement (FOA) solicits applications from single institutions or consortia of institutions to establish a Coordination and Data Sharing Center (CDSC) in support of the… More
Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Centers for Bunyavirales, Paramyxoviridae and Picornaviridae (U19 Clinical Trial Not Allowed) RFA-AI-23-020 NIAID This Funding Opportunity Announcement (FOA) solicits applications from single institutions or consortia of institutions to participate in the Research and Development of Vaccines and Monoclonal… More
Consortium for Food Allergy Research: Leadership Center (UM1 Clinical Trial Required) RFA-AI-22-077 NIAID The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for the Leadership Center of the NIAID Consortium for Food Allergy Research (CoFAR). The CoFAR Leadership Center… More
Consortium for Food Allergy Research: Clinical Research Center (U01 Clinical Trial Required) RFA-AI-22-076 NIAID The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for the Clinical Research Centers (CRC) for the NIAID Consortium for Food Allergy Research (CoFAR). The CoFAR-… More
Sexually Transmitted Infections (STI) Cooperative Research Centers (CRC): Vaccine Development (U01 Clinical Trial Not Allowed) RFA-AI-23-008 NIAID The purpose of this Funding Opportunity Announcement (FOA) is to advance vaccine candidates for gonorrhea, chlamydia and syphilis by supporting IND-enabling activities. Applications must include a… More
Exploratory Data Science Methods and Algorithm Development in Infectious and Immune-mediated Diseases (R21 Clinical Trial Not Allowed) RFA-AI-21-035 NIAID The purpose of this Funding Opportunity Announcement (FOA) is to support exploratory research focused on developing innovative methods and algorithms in biomedical computing, informatics, and data… More
Early-Stage Development of Data Science Technologies for Infectious and Immune-mediated Diseases (U01 Clinical Trial Not Allowed) RFA-AI-21-020 NIAID The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for the development of enabling data science technologies to improve the acquisition, management, analysis,… More
Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11 Clinical Trial Not Allowed) PAR-21-037 NIAID The purpose of this Funding Opportunity Announcement (FOA) is to invite applications from research institutions in low- to middle-income countries (LMIC) to provide senior administrators from these… More
Defining Mechanisms of HIV Induced Inflammation and Immune Activation During Suppressive Antiretroviral Therapy (ART) (R01 Clinical Trial Not Allowed) RFA-AI-23-018 NIAID This Funding Opportunity Announcement (FOA) encourages research focused on defining the molecular mechanisms by which HIV proteins and/or nucleic acids induce inflammation, immune activation and HIV… More
NIAID Research Education Program Advancing the Careers of a Diverse Research Workforce (R25 Clinical Trial Not Allowed) PAR-21-258 NIAID The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this NIAID R25 program is to support educational activities… More
Limited Competition: Exploratory and Developmental Research Grant Program for NIAID K01/K08/K23 Recipients (R21 Clinical Trial Not Allowed) PAR-20-291 NIAID The National Institute of Allergy and Infectious Diseases (NIAID) announces a program that provides NIAID-supported K01, K08, and K23 recipients with the opportunity to apply for Exploratory and… More
Limited Competition: Small Research Grant Program for NIAID K01/K08/K23 Recipients (R03 Clinical Trial Not Allowed) PAR-20-290 NIAID The National Institute of Allergy and Infectious Diseases (NIAID) announces a program that provides NIAID-supported K01, K08, and K23 recipients with the opportunity to apply for Small Research Grant… More
NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44 Clinical Trial Required) PAR-21-082 NIAID This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to implement investigator-… More
NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required) PAR-21-083 NIAID This Funding Opportunity Announcement (FOA) encourages cooperative agreement applications for implementation of investigator-initiated, high-risk clinical trials and mechanistic studies associated… More
Notice of Special Interest (NOSI): Administrative Supplements for R25 Data Science Training for Infectious and Immune-mediated Disease Research NOT-AI-23-010 NIAID The purpose of this Notice of Special Interest (NOSI) is to highlight the interest of participating NIH institutes and centers (ICs) to enhance existing NIH research Education (R25) awards with data… More
Notice of Special Interest (NOSI): Harnessing Big Data to Halt HIV NOT-AI-21-054 NIAID The purpose of this Notice of Special Interest (NOSI) is to promote and support innovative methods in Big Data Science (BDS) to identify unappreciated biomedical, behavioral, social patterns and… More
NIAID Research Education Program (R25 Clinical Trial Not Allowed) PAR-22-134 NIAID The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this National Institute of Allergy and infectious Diseases (… More
Next Generation Multipurpose Prevention Technologies (NGM) (R01 Clinical Trial Optional) PAR-22-222 NIAID The objective of this Funding Opportunity Announcement (FOA) is to support the continued development of new and innovative on-demand, event-driven, and long-acting (systemic and non-systemic)… More
Transgender People: Immunity, Prevention, and Treatment of HIV and STIs (R21 Clinical Trial Not Allowed) PAR-22-186 NIAID The purpose of this Funding Opportunity Announcement (FOA) is to support hypothesis-generating research in transgender people with the objective of characterizing the biological and immunological… More
Identifying Host Cell Death Pathway Targets for Host-Directed Therapies for Treatment of Mtb and Mtb/HIV Co-Infection (R01 Clinical Trial Not Allowed) PAR-22-223 NIAID The purpose of this Funding Opportunity Announcement (FOA) is to support mechanistic studies on host cell death pathways and immune responses to Mycobacterium tuberculosis (Mtb) and Mtb/HIV co-… More
NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed) PAR-22-075 NIAID The purpose of the NIAID Career Transition Award (CTA) program is to assist postdoctoral fellows' transition to positions of assistant professor or equivalent and initiate a successful… More
Resources Access for Preclinical Integrated Drug Development (RAPIDD) Program (X01 Clinical Trial Not Allowed) PAR-22-185 NIAID The purpose of this FOA is to provide a method for investigators to request gap filling preclinical services to academic and private institutions to assist with product development efforts and… More
Integrated Preclinical / Clinical AIDS Vaccine Development Program (IPCAVD) (U19 Clinical Trial Not Allowed) PAR-23-033 NIAID The purpose of this Funding Opportunity Announcement (FOA) is to support translation of advanced HIV-1 vaccine candidates from pre-clinical studies through different phases of process and product… More
Centers for AIDS Research (P30 Clinical Trial Not Allowed) PAR-23-116 NIAID The purpose of this Funding Opportunity Announcement (FOA) is to invite applications for the Centers for AIDS Research (CFAR) program to provide administrative and shared research support to enhance… More
Developmental Centers for AIDS Research (P30 Clinical Trial Not Allowed) PAR-23-117 NIAID The purpose of this Funding Opportunity Announcement (FOA) is to invite applications for the Developmental Centers for AIDS Research (D-CFAR) program to provide administrative and shared research… More
NIH Medical Scientist Partnership Program (FM1 Clinical Trial Not Allowed) PAR-23-109 NIAID The purpose of the MSPP is to develop a diverse pool of combined-degree students (e.g., MD/PhD, DDS/PhD, DVM/PhD) who have conducted their PhD dissertation research at research laboratories in the… More
NIAID Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional) PAR-22-241 NIAID This Funding Opportunity Announcement (FOA) solicits R01 grant applications that propose independent research projects that are within the scientific mission areas of the participating NIH Institutes… More
NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed) PAR-22-225 NIAID This Funding Opportunity Announcement (FOA) invites submission of investigator-initiated Program Project (P01) applications. The proposed programs should address scientific areas relevant to the… More
NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed) PAR-23-065 NIAID This Funding Opportunity Announcement (FOA), issued by the National Institute of Allergy and Infectious Diseases (NIAID), invites applications for investigator-initiated Resource-Related Research… More
NIAID Physician-Scientist Pathway to Independence Award (K99/R00 Independent Clinical Trial Not Allowed) PAR-23-071 NIAID The purpose of the NIAID Physician-Scientist Pathway to Independence Award (K99/R00) program is to increase and maintain a strong cohort of new and talented independent physician-scientists. This… More
Mentored Career Development Program for Early Stage Investigators Using Nonhuman Primate Research Models (K01 Independent Clinical Trial Not Allowed) PAR-23-073 NIAID The purpose of this Funding Opportunity Announcement (FOA) is to provide early-stage investigators with support and protected time (up to five years) for intensive, research-focused career… More
NIAID Physician-Scientist Pathway to Independence Award (K99/R00 Clinical Trial Required) PAR-23-070 NIAID The purpose of the NIAID Physician-Scientist Pathway to Independence Award (K99/R00) program is to increase and maintain a strong cohort of new and talented independent physician-scientists. This… More
Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required) PAR-23-084 NIAID This Funding Opportunity Announcement (FOA) invites applications for implementation of investigator-initiated clinical trials requiring an extended project period of 6 or 7 years. The trials can be… More
NIAMS Skin Biology and Diseases Resource-based Centers (P30 - Clinical Trial Not Allowed) RFA-AR-24-001 NIAMS NIAMS Skin Biology and Diseases Resource-based Centers (P30 - Clinical Trial Not Allowed)
NIAMS Resource-based Centers for Bone, Muscle and Orthopaedic Research (P30 - Clinical Trial Not Allowed) RFA-AR-24-002 NIAMS NIAMS Resource-based Centers for Bone, Muscle and Orthopaedic Research (P30 - Clinical Trial Not Allowed)
Notice of Special Interest: Promoting Research on Mechanisms of Pathogenesis and Pathophysiology of Atypical Femoral Fracture (AFF) and Osteonecrosis of the Jaw (ONJ) NOT-AR-21-006 NIAMS Notice Special Interest: Promoting Research Mechanisms Pathogenesis Pathophysiology Atypical Femoral Fracture AFF) Osteonecrosis the Jaw ONJ) Notice Number: NOT-AR-21-006 Key Dates Release Date:… More
NIAMS Clinical Trial Planning Grant (R34) - Clinical Trial Not Allowed PAR-22-205 NIAMS NIAMS Clinical Trial Planning Grant (R34) - Clinical Trial Not Allowed Re-Issue
Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed) PAR-21-053 NIAMS Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)
NIAMS Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required) PAR-21-036 NIAMS NIAMS Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)
Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R21 Clinical Trial Required) PAR-21-045 NIAMS Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R21 Clinical Trial Required)
Limited Competition: Promoting a Basic Understanding of Chemical Threats to Skin (R34 Clinical Trial Not Allowed) PAS-21-245 NIAMS Promoting a Basic Understanding of Chemical Threats to Skin (R34 Clinical Trial not allowed)
Limited Competition: Small Grant Program for NIAMS K01, K08, K23, and K25 Recipients (R03) (Clinical Trials Not Allowed) PAR-22-119 NIAMS Limited Competition: Small Grant Program for NIAMS K01, K08, K23, and K25 Recipients (R03)
Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed) PAR-23-032 NIAMS Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not… More
Ancillary Studies to Ongoing Clinical Projects (R01 Clinical Trial Not Allowed) PAR-23-025 NIAMS Ancillary Studies to Ongoing Clinical Projects (R01 Clinical Trial Not Allowed)
Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed) PAR-23-026 NIAMS Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed)
National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Optional) PAR-20-169 NIBIB This Funding Opportunity Announcement (FOA) encourages grant applications for Biomedical Technology Resource Centers (BTRCs). BTRCs are national resource centers for conducting research and… More
NIBIB Biomaterials Network Technology Development Coordinating Center (U24 Clinical Trial Not Allowed) RFA-EB-23-002 NIBIB The purpose of this funding opportunity announcement (FOA) is to
Research on Bioethical Issues Related to Bionic and Robotic Device Development and Translation (R21 Clinical Trial Optional) RFA-EB-23-001 NIBIB Ethical considerations are intrinsic to the conduct of robotic and bionic device research. This Funding Opportunity Announcement (FOA) invites applications that propose research on ethical questions… More
BRAIN Initiative: Transformative Brain Non-invasive Imaging Technology Development (UG3/UH3 Clinical Trial Not Allowed) RFA-EB-22-003 NIBIB This Funding Opportunity Announcement (FOA) solicits applications for team-centric development and validation of innovative non-invasive imaging technologies that could have a transformative impact… More
Technology Development to Reduce Health Disparities (R01 Clinical Trial Optional) RFA-EB-21-001 NIBIB The purpose of this funding opportunity is to reduce health disparities through the development and translation of appropriate medical technologies. The NIH defines health disparities as differences… More
Team-Based Design in Biomedical Engineering Education (R25 Clinical Trial Not Allowed) PAR-22-000 NIBIB The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NIBIB R25 program is to support educational activities… More
Bioengineering Partnerships with Industry (U01 Clinical Trial Optional) PAR-22-123 NIBIB This Funding Opportunity Announcement (FOA) solicits applications from research partnerships formed by academic and industrial investigators to accelerate the development and adoption of promising… More
HEAL Initiative: Translational Development of Diagnostic and Therapeutic Devices (R18 Clinical Trial Not Allowed) RFA-EB-22-002 NIBIB The purpose of this Funding Opportunity Announcement (FOA) is to develop clinical-grade prototypes intended for use as safe, effective, and non-addictive device-based technologies and approaches to… More
Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional) PAR-24-022 NIBIB This Trailblazer Award is an opportunity for NIH-defined New and Early Stage Investigators (https://grants.nih.gov/policy/early-investigators/index.htm) to pursue research programs that integrate… More
Physiomimetics and Organoids for Reproductive Health (R01 Clinical Trial Not Allowed) RFA-HD-23-024 NICHD This Funding Opportunity Announcement (FOA) invites grant applications to develop physiomimetic platforms and organoid culture systems for studies of the female reproductive tract and gametogenesis (… More
Pediatric Critical Care and Trauma Scientist Development Program (K12 Clinical Trial Optional) RFA-HD-24-001 NICHD The purpose of this Funding Opportunity Announcement (FOA) is to invite applications to support a national program of mentored advanced career development and training in research for junior faculty… More
Physiomimetics and Organoids for Reproductive Health (R21 Clinical Trial Not Allowed) RFA-HD-23-025 NICHD This Funding Opportunity Announcement (FOA) invites grant applications to develop physiomimetic platforms and organoid culture systems for studies of the female reproductive tract and gametogenesis (… More
Development of Novel Nonsteroidal Contraceptive Methods (R61/R33 - Clinical Trial Not Allowed) RFA-HD-24-002 NICHD The purpose of this funding opportunity announcement (FOA) is to support and facilitate multidisciplinary research approaches for the development of novel nonsteroidal contraceptive products for men… More
Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 - Clinical Trial Not Allowed) RFA-HD-24-006 NICHD The purpose of this Funding Opportunity Announcement (FOA) is to address the needs of the maternal and pediatric HIV scientific community for research data translation and sharing. This initiative… More
NICHD Biomedical Informatic Resource Centers Grants (P41 Clinical Trial Not Allowed) PAR-20-126 NICHD The purpose of this Funding Opportunity Announcement (FOA) is to support the continued operation, enhancement, and dissemination of unique database resources and/or bioinformatics tools that are of… More
Notice of Special Interest (NOSI): Climate Change and Health Administrative Supplements NOT-HD-23-006 NICHD The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), in partnership with the National Institute of Environmental Health Science (NIEHS), Fogarty International… More
Fertility Status as a Marker for Overall Health (R21 Clinical Trial Not Allowed) PAR-20-282 NICHD T?he purpose of this funding opportunity announcement (FOA) is to support exploratory/developmental research that explores the premise that fertility status can be a marker for overall health.… More
Fertility Status as a Marker for Overall Health (R01 Clinical Trial Optional) PAR-20-281 NICHD The purpose of this funding opportunity (FOA) is to support research that explores the premise that fertility status can be a marker for overall health. Chronic conditions such as concer, diabetes,… More
Opportunities for Advancing Limb Regeneration Research (R01 Clinical Trial Not Allowed) RFA-HD-24-004 NICHD The purpose of this Funding Opportunity Announcement (FOA) is to promote transformative basic research on limb regeneration using animal models. The primary focus is on gaining insight into the bodys… More
Population Dynamics Centers Research Infrastructure Program FY 2024 (P2C Clinical Trial Not Allowed) RFA-HD-24-008 NICHD The goal of this funding opportunity announcement (FOA) is to advance the field of population dynamics research by increasing research impact, innovation, and productivity; developing junior… More
Development of the Fetal Immune System (R01 Clinical Trial Not Allowed) PAR-20-298 NICHD The purpose of this Funding Opportunity Announcement (FOA) is to understand the contribution of specific elements of maternal molecular and cellular factors that can control and effect the… More
Multipurpose Prevention Technology: Novel Systemic Options for Young Adults (R41/R42 Clinical Trial Not Allowed) PAR-21-298 NICHD The objective of this Funding Opportunity Announcement (FOA) is to support the development of new and innovative long-acting systemic and non-systemic multipurpose prevention technologies (MPT). It… More
Multipurpose Prevention Technology: Novel Systemic Options for Young Adults (R43/R44 Clinical Trial Not Allowed) PAR-21-297 NICHD The objective of this Funding Opportunity Announcement (FOA) is to support the development of new and innovative long-acting systemic and non-systemic multipurpose prevention technologies (MPT). It… More
Pre-application: Opportunities for Collaborative Research at the NIH Clinical Center (X02 Clinical Trial Optional) PAR-21-342 NICHD The goal of this program is to support collaborative translational research projects aligned with NIH efforts to enhance the translation of basic biological discoveries into clinical applications… More
Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional) PAR-21-115 NICHD This funding opportunity announcement (FOA) encourages applications that propose to develop studies that will lead to a broad understanding of the natural history of disorders that already do or… More
Opportunities for Collaborative Research at the NIH Clinical Center (U01 Clinical Trial Optional) PAR-21-343 NICHD The goal of this program is to support collaborative translational research projects aligned with NIH efforts to enhance the translation of basic biological discoveries into clinical applications… More
NICHD Small Research Grant Program (R03 Basic Experimental Studies with Humans Required) PA-21-231 NICHD The NICHD Small Research Grant Program (Clinical Trial Required) supports clinical trials that fall within the NICHD mission.
This funding opportunity announcement is for basic science… More
Pediatric Immune System Ontogeny and Development (INTEND) (R01 Clinical Trial Not Allowed) PAR-21-248 NICHD The purpose of this Funding Opportunity Announcement (FOA) is to correlate immune systemdevelopment patterns between two or more age groups- neonates, infants, and children and adolescents and… More
NICHD Small Research Grant Program (R03 Clinical Trial Required) PA-21-221 NICHD The NICHD Small Research Grant Program (Clinical Trial Required) supports clinical trials that fall within the NICHD mission.
Notice of Special Interest (NOSI) - Emerging and Existing Issues of Coronavirus Disease 2019 (COVID-19) Research Related to the Health and Well-Being of Women, Children and Individuals with Physical and/or Intellectual Disabilities NOT-HD-22-002 NICHD The purpose of this funding opportunity is to provide an avenue for researchers to pursue funding to conduct research addressing these emerging and existing COVID-related issues. The goal of this… More
Advancing Methods for Safe, Noninvasive, Real Time Assessment of Placenta Development and Function Across Pregnancy (R01 Clinical Trial Not Allowed) PAR-22-237 NICHD This Funding Opportunity Announcement (FOA) invites grant applications that seek to advance or clinically validate emerging novel approaches for the development of safe, real-time, non-invasive (or… More
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional) PAR-21-353 NICHD This FOA encourages research relevant to the development of novel screening approaches and/or therapeutic interventions for potentially fatal or disabling conditions that have been identified through… More
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R03 - Clinical Trial Optional) PAR-21-354 NICHD This FOA encourages research relevant to the development of novel screening approaches and/or therapeutic interventions for potentially fatal or disabling conditions that have been identified through… More
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional) PAR-21-355 NICHD This FOA encourages research relevant to the development of novel screening approaches and/or therapeutic interventions for potentially fatal or disabling conditions that have been identified through… More
Advancing Methods for Safe, Noninvasive, Real Time Assessment of Placenta Development and Function Across Pregnancy (R21 Clinical Trial Not Allowed) PAR-22-236 NICHD This Funding Opportunity Announcement (FOA) invites grant applications that seek to advance or clinically validate emerging novel approaches for the development of safe, real-time, non-invasive (or… More
Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required) PAR-21-357 NICHD The purpose of the Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools is to support small scale research grants at institutions that do not receive… More
NCMRR Early Career Research Award (R03 Clinical Trial Optional) PAR-23-029 NICHD The National Center for Medical Rehabilitation Research (NCMRR) Early Career Research (ECR) Award (R03) is intended to support both basic and clinical research from rehabilitation scientists who are… More
Biological Testing Facility (X01 Clinical Trial Not Allowed) PAR-23-128 NICHD The purpose of this funding opportunity announcement (FOA) is to provide investigators with a mechanism to request services from this facility that would advance their contraceptive development… More
Screening and Functional Validation of Human Birth Defects Genomic Variants (R01 Clinical Trial Not Allowed) PAR-21-229 NICHD Rapid advances in genotyping and next generation sequencing technologies have led to the identification of genetic variants that are associated with a wide variety of congenital defects including… More
NICHD Research Education Programs (R25 Clinical Trial Not Allowed) PAR-22-224 NICHD This FOA will support creative educational activities that focus primarily on research skills development. . Although activities focused primarily on mentoring activities or professional skills… More
Advancing Research to Understand Congenital Malformations (R01 Clinical Trial Not Allowed) PAR-22-215 NICHD The purpose of this funding opportunity announcement (FOA) is to support innovative research that will inform our understanding of the mechanisms underlying the formation of structural birth defects… More
Archiving and Documenting Child Health and Human Development Data Sets (R03 Clinical Trial Not Allowed) PAR-22-261 NICHD The purpose of this funding opportunity announcement (FOA) is to invite R03 applications to support archiving and documenting existing data sets in order to enable secondary analysis of these data by… More
In-Depth Phenotyping and Research Using IMPC-Generated Knockout Mouse Strains Exhibiting Embryonic or Perinatal Lethality or Subviability (R01 Clinical Trial Not Allowed) PAR-23-074 NICHD The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications to phenotype and/or perform research on embryonic lethal knockout (KO) mouse strains being generated through… More
Small Research Grants for Analyses of Gabriella Miller Kids First Pediatric Research Data (R03 Clinical Trial Not Allowed) PAR-23-075 NICHD The NIH Common Fund has established the Gabriella Miller Kids First Pediatric Research Program (Kids First) to develop a pediatric research data resource populated by genome sequence and phenotypic… More
Multisite Clinical Research: Leveraging Network Infrastructure to Advance Research for Women, Children, Pregnant and Lactating Individuals, and Persons with Disabilities (U01 Clinical Trial Optional) PAR-23-037 NICHD The purpose of this funding opportunity announcement (FOA) is to invite applications for multisite clinical trials and observational studies developed in conjunction with NICHD Networks that will be… More
Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional) PAR-23-131 NICHD The purpose of this funding opportunity announcement (FOA) is to support translational and clinical research to (1) advance precision medicine in pregnant persons, lactating persons, and children… More
Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional) PAR-23-130 NICHD The purpose of this funding opportunity announcement (FOA) is to support translational and clinical research to (1) advance precision medicine in pregnant persons, lactating persons, and children… More
NIDA Program Project Grant Applications (P01 Clinical Trial Optional) PAR-22-201 NIDA This Funding Opportunity Announcement (FOA) announces the availability of support for collaborative research by multi-disciplinary teams which is of high priority to NIDA and leads to synergistic… More
Notice of Special Interest (NOSI): Biomarkers and Biotypes of Drug Addiction NOT-DA-20-012 NIDA Notice Special Interest NOSI): Biomarkers Biotypes Drug Addiction Notice Number: NOT-DA-20-012 Key Dates Release Date: January 06, 2020 First Available Due Date: February 05, 2020 Expiration Date:… More
Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional) PAR-19-282 NIDA This Funding Opportunity Announcement (FOA) uses a R61/R33 Phased Innovation Award mechanism to support clinical research applications that are exploratory and developmental in nature and focus on… More
Extracellular RNA carrier subclasses in processes relevant to Substance Use Disorders or HIV infection (R01- Clinical Trial Not Allowed) PAR-20-147 NIDA The purpose of this FOA is to encourage research investigating the roles of extracellular RNA (exRNA) carrier subclasses in biological processes relevant to substance use disorders (SUDs) and/or HIV… More
Substance Use/Substance Use Disorder Dissertation Research Award (R36 - Clinical Trials Optional) PA-20-208 NIDA The goal of this FOA is to support doctoral candidates from a variety of academic disciplines for up to two years for the completion of the doctoral dissertation research project. Research projects… More
NIDA Small Research Grant Program (R03 Clinical Trial Required) PA-20-146 NIDA The NIDA Small Research Grant Program supports small research projects that can be carried out in a short period of time with limited resources. This program supports different types of projects… More
Extracellular RNA carrier subclasses in processes relevant to Substance Use Disorders or HIV infection (R21- Clinical Trial Not Allowed) PAR-20-148 NIDA The purpose of this FOA is to encourage research investigating the roles of extracellular RNA (exRNA) carrier subclasses in biological processes relevant to substance use disorders (SUDs) and/or HIV… More
NIDA Translational Avant-Garde Award for Development of Medication to Treat Substance Use Disorders (UG3/UH3 Clinical Trial Optional) PAR-21-092 NIDA The purpose of this award is to support outstanding basic and/or clinical researchers with the vision and expertise to translate research discoveries into medications for the treatment of Substance… More
Mechanisms and Targets at the Intersection of HIV and Substance Use (R21 Clinical Trials Not Allowed) RFA-DA-24-014 NIDA The purpose of this FOA is to support basic research on signaling pathways and mechanisms including HIV-host protein interactions and post-translational modifications by which addictive drugs and HIV… More
Mechanisms and Targets at the Intersection of HIV and Substance Use (R01 Clinical Trials Not Allowed) RFA-DA-24-013 NIDA The purpose of this FOA is to support basic research on signaling pathways and mechanisms including HIV-host protein interactions and post-translational modifications by which addictive drugs and HIV… More
Device-Based Treatments for Substance Use Disorders (UG3/UH3, Clinical Trial Optional) PAR-20-279 NIDA The purpose of this Funding Opportunity Announcement (FOA) is to accelerate the development of devices to treat Substance Use Disorders (SUDs). The continuing advances in technologies offer… More
Leveraging Big Data Science to Elucidate the Mechanisms of HIV Activity and Interaction with Substance Use Disorder (R01 Clinical Trials Not Allowed) RFA-DA-24-008 NIDA The purpose of this FOA is to attract data and computational scientists to propose novel ways to integrate data of different types and scales to allow new types of analysis. It is expected that with… More
Leveraging Big Data Science to Elucidate the Mechanisms of HIV Activity and Interaction with Substance Use Disorder (R21 Clinical Trials Not Allowed) RFA-DA-24-009 NIDA The purpose of this FOA is to attract data and computational scientists to propose novel ways to integrate data of different types and scales to allow new types of analysis. It is expected that with… More
New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R01 Clinical Trial Required) PAR-20-273 NIDA The purpose of this FOA is to support the testing of enhanced models of care that optimally integrate HIV, addiction, and primary care services.
Pathogenic Mechanisms influencing Blood Brain Barrier function in HIV and Substance Use Disorders (R01 Clinical Trial Optional) RFA-DA-23-012 NIDA The blood brain barrier (BBB) is a target of both the HIV virus and substances of abuse. It is a site of entry for HIV infected monocytes and macrophages that can traverse the BBB either… More
Implementing Comprehensive HIV services in Syringe Service Program (SSP) Settings (R01 - Clinical Trial Required) RFA-DA-23-006 NIDA There has been a substantial increase in the number of syringe service programs (SSPs) in the US and the range of these settings has become broader, with many now located in health department or… More
New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R34 - Clinical Trial Optional ) PAR-20-274 NIDA This funding opportunity announcement will support the development and testing of enhanced models of care that are able to optimally integrate HIV, addiction, and primary care services.
Implementing Comprehensive HIV services in Syringe Service Program (SSP) Settings (R34 - Clinical Trial Required) RFA-DA-23-007 NIDA There has been a substantial increase in the number of syringe service programs (SSPs) in the US and the range of these settings has become broader, with many now located in health department or… More
Notice of Special Interest (NOSI): Harnessing computational tools for sophisticated analyses of Substance Use Disorder-related behaviors NOT-DA-20-017 NIDA Notice Special Interest NOSI): Harnessing computational tools sophisticated analyses Substance Disorder-related behaviors Notice Number: NOT-DA-20-017 Key Dates Release Date: March 5, 2020 First… More
Research to Improve Native American Health (R21 Clinical Trials Optional) PAR-20-214 NIDA The purpose of this funding opportunity announcement (FOA) is to support developmental/exploratory studies in preparation for health promotion, disease prevention, treatment, or treatment services… More
Notice of Special Interest (NOSI): Advancing Research on SUD through Computational Neuroscience NOT-DA-20-022 NIDA Notice Special Interest NOSI): Advancing Research SUD through Computational Neuroscience Notice Number: NOT-DA-20-022 Key Dates Release Date: 05, 2020 First Available Due Date: June 05, 2020… More
Notice of Special Interest (NOSI):Sleep and Substance Use Disorders NOT-DA-20-021 NIDA Notice Special Interest NOSI): Sleep Substance Disorders Notice Number: NOT-DA-20-021 Key Dates Release Date: March 25, 2020 First Available Due Date: June 05, 2020 Expiration Date: September 08,… More
Notice of Special Interest (NOSI): Cannabis, Prescription Opioid, or Prescription Benzodiazepine Drug Use Among Older Adults NOT-DA-20-014 NIDA Notice Special Interest NOSI): Cannabis, Prescription Opioid, Prescription Benzodiazepine Drug Among Older Adults Notice Number: NOT-DA-20-014 Key Dates Release Date: April 22, 2020 First Available… More
Notice of Special Interest (NOSI): Human Molecular Genetics of Substance Use Disorders NOT-DA-20-030 NIDA Notice Special Interest NOSI): Human Molecular Genetics Substance Disorders Notice Number: NOT-DA-20-030 Key Dates Release Date: March 5, 2020 First Available Due Date: une 05, 2020 Expiration Date… More
Notice of Special Interest (NOSI): Mentored Career Development Award in Large-Scale Clinical Study Development and Analysis NOT-DA-20-006 NIDA Notice Special Interest NOSI): Mentored Career Development Award Large-Scale Clinical Study Development Analysis Notice Number: NOT-DA-20-006 Key Dates Release Date: March 5, 2020 First Available… More
Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) PAR-20-238 NIDA The purpose of this funding opportunity announcement (FOA) is to support research on interventions to improve health in Native American (NA) populations. This includes 1) etiologic research, where… More
Notice of Special Interest (NOSI): Going Global: Using Gene Network Analyses to Understand the Etiology of SUD NOT-DA-20-020 NIDA Notice Special Interest NOSI): Going Global: Using Gene Network Analyses Understand Etiology SUD Notice Number: NOT-DA-20-020 Key Dates Release Date: February 24, 2020 First Available Due Date: June… More
Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01) PAR-21-044 NIDA The Population Assessment of Tobacco and Health (PATH) Study provides the scientific community with biospecimens (urine, plasma, and serum) and related research data on behaviors, attitudes,… More
NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional) PAR-20-249 NIDA This funding opportunity announcement (FOA) encourages applications for institutional research career development (K12) programs that propose to support intensive supervised research training and… More
Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R34 Clinical Trial Optional) PAR-21-023 NIDA As part of the Collaborative Research on Addiction at NIH (CRAN) initiative, NIDA, NIAAA, and NCI join to issue this FOA. The purpose of this FOA is to support the development and testing of… More
Providing Research Education Experiences to Enhance Diversity in the Next Generation of Substance Use and Addiction Scientists (R25 Clinical Trials Not Allowed) PAR-20-236 NIDA The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this R25 program is to support educational activities that… More
Genetic analysis of non-human animal models to understand the genomic architecture of substance use disorders and addictive behaviors (U01 Clinical Trial Not Allowed) PAR-18-789 NIDA The goals of this initiative are to discover allelic variants, genomic alterations, and functional changes associated with addictive behaviors in non-human animals through systems studies that employ… More
Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3 Clinical Trial optional) PAR-21-183 NIDA The purpose of this Funding Opportunity Announcement (FOA) is to accelerate the development of Digital Therapeutics (DTx) to treat Substance Use Disorders (SUDs). Advances in technology offer… More
Education Activities for Responsible Analyses of Complex, Large-Scale Data (R25- Clinical Trial Not Allowed) RFA-DA-24-027 NIDA This concept proposes to advance methodological rigor in NIDA-relevant research by supporting training on the responsible analyses of complex, large-scale datasets involving brain, behavioral,… More
High Priority HIV and Substance Use Research (R01 Clinical Trial Optional) RFA-DA-22-040 NIDA The purpose of this Funding Opportunity Announcement (FOA) is to support high priority research at the intersection of HIV and substance use. This FOA invites innovative research projects with the… More
NIDA Animal Genomics Program (U01 Clinical Trial Not Allowed) PAR-21-244 NIDA The purpose of the NIDA Animal Genetics Program is to identify genetic, genomic, and molecular (epi)genetic variants that underlie: 1. Phenotypes associated with addictive behaviors and/or… More
Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional) PAR-21-208 NIDA The National Institute on Drug Abuse (NIDA) Cutting-Edge Basic Research Award (CEBRA) is designed to foster highly innovative or conceptually creative research related to the etiology,… More
HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R61/R33 Clinical Trial Optional) RFA-DA-23-053 NIDA This RFA will act as a parent RFA for the HEAL initiative Translation to Practice Team, specifically encouraging translational dissemination and implementation research focused on addressing… More
HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R33 Clinical Trial Optional) RFA-DA-23-054 NIDA This RFA will act as a parent RFA for the HEAL initiative Translation to Practice Team, specifically encouraging translational dissemination and implementation research focused on addressing overdose… More
Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 Clinical Trial Required) PAR-21-154 NIDA The purpose of this Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions is to support small scale research grants at institutions that do not receive substantial funding… More
Pilot and Feasibility Studies in Preparation for Substance Use Prevention Trials (R34 Clinical Trial Optional) PA-21-110 NIDA The purpose of this Funding Opportunity Announcement (FOA) is to encourage pilot and/or feasibility research in the following areas: 1) the development and pilot testing of new or adapted… More
Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 - Clinical Trial Optional) PA-21-180 NIDA This Funding Opportunity Announcement (FOA) encourages pilot and preliminary research in preparation for larger-scale services research effectiveness trials. Relevant trials may test a wide range of… More
Development and Testing of Novel Interventions to improve HIV Prevention, Treatment, and Program Implementation for People Who Use Drugs (R34 Clinical Trial Required) PA-21-205 NIDA This Funding Opportunity Announcement (FOA) encourages formative research, intervention development, and pilot-testing of interventions. Primary scientific areas of focus include the feasibility,… More
Blueprint Medtech: Small Business Translator (U44 - Clinical Trial Optional) PAR-21-282 NIDA The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications from Small Business Concerns (SBCs) to pursue translational activities and limited-size clinical studies to… More
NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed) PAR-21-320 NIDA The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NIDA R25 program is to support educational activities… More
Imaging - Science Track Award for Research Transition (I/START) (R03- Clinical Trial Optional) PAR-21-310 NIDA This funding opportunity announcement (FOA) encourages Small Research Grant (R03) applications to facilitate the entry of investigators to the area of neuroimaging, including both new investigators… More
Notice of Special Interest (NOSI): Using Data to Advance HIV Epidemic Knowledge and Program Planning NOT-DA-21-007 NIDA The purpose of this Notice is to encourage grant applications proposing research that makes use of available, large data sets with the objective of improving HIV epidemic modeling and service… More
Imaging - Science Track Award for Research Transition (I/START) (R03- Basic Experimental Studies with Humans Required) PAR-21-309 NIDA This funding opportunity announcement (FOA) encourages Small Research Grant (R03) applications to facilitate the entry of investigators to the area of neuroimaging, including both new investigators… More
AIDS-Science Track Award for Research Transition (R03 Clinical Trial Optional) PAS-21-270 NIDA This funding opportunity announcement (FOA) seeks to facilitate the entry of both newly independent and early career investigators to the area of drug use and use disorder research and HIV/AIDS. This… More
Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional) PAR-22-027 NIDA This Funding Opportunity Announcement (FOA) will support pilot, feasibility or exploratory research in 5 priority areas in substance use epidemiology and health services, including: 1) responses to… More
BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed) RFA-DA-23-039 NIDA This FOA solicits the development of theories, computational models, and analytical tools to derive understanding of brain function from complex neuroscience data. Proposed projects could develop… More
Stimulants and HIV: Addressing Contemporary and Recurring Epidemics (R61/R33 - Clinical Trial Required) RFA-DA-23-008 NIDA Stimulant use has been increasing among opioid users since 2016, based on overdose data and this makes control of the opioid epidemic more difficult, as it occurs in addition to the continuing influx… More
NIDA REI: Racial Equity Visionary Award Program for Research on Substance Use and Racial Equity (DP1 Clinical Trial Optional) RFA-DA-23-026 NIDA This initiative invites applications for DP1 awards to support exceptionally creative early career investigators who propose high-impact projects that lead to advances in equity across populations… More
NIDA REI: Research at Minority Serving Institutions on Neurocognitive Mechanisms Underlying the Impact of Structural Racism on the Substance Use Trajectory (R61/R33 Clinical Trial Optional) RFA-DA-23-029 NIDA NEPS Concept # 1862
This concept seeks to support exploratory basic research on interpersonal racism and on parsing the complex effects of structural racism into sub-components and their impact… More
NIDA REI: Addressing Racial Equity in Substance Use and Addiction Outcomes Through Community-Engaged Research (R01 Clinical Trial Optional) RFA-DA-23-013 NIDA NEPS Concept # 1875
This FOA invites R01 applications?to conduct research that will have a major impact in identifying, developing, implementing, or testing strategies to prevent, reduce, or… More
NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial and/or Ethnic Populations (R01 Clinical Trial Optional) RFA-DA-23-061 NIDA This Funding Opportunity Announcement (FOA) is a part of NIDAs Racial Equity Initiative (REI), a multi-year, multi-pronged effort to eliminate racial inequities in NIDAs workplace, scientific… More
NIDA REI: Research on Neurocognitive Mechanisms Underlying the Impact of Structural Racism on the Substance Use Trajectory (R61/R33 Clinical Trial Optional) RFA-DA-23-028 NIDA NEPS Concept # 1862
This concept seeks to support exploratory basic research on interpersonal racism and on parsing the complex effects of structural racism into sub-components and their impact… More
NIDA REI: Racial Equity Visionary Award Program for Research at Minority Serving Institutions on Substance Use and Racial Equity (DP1 Clinical Trial Optional) RFA-DA-23-031 NIDA This initiative invites applications for DP1 awards to support exceptionally creative early career investigators who propose high-impact projects that lead to advances in equity across populations… More
NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial and/or Ethnic Populations (R34 Clinical Trial Optional) RFA-DA-23-062 NIDA This Funding Opportunity Announcement (FOA) is a part of NIDAs Racial Equity Initiative (REI), a multi-year, multi-pronged effort to eliminate racial inequities in NIDAs workplace, scientific… More
NIDA REI: Addressing Racial Equity in Substance Use and Addiction Outcomes Through Community-Engaged Research at Minority Serving Institutions (R01 Clinical Trial Optional) RFA-DA-23-032 NIDA NEPS Concept # 1875
This funding opportunity announcement (FOA)?is a part of?NIDAs Racial Equity Initiative.?This?multi-year,?multi-pronged effort?to address ?racial and ethnic inequities in… More
NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial/Ethnic Populations (R01 Clinical Trial Optional) RFA-DA-23-023 NIDA This Funding Opportunity Announcement (FOA) is a part of NIDAs Racial Equity Initiative (REI), a multi-year, multi-pronged effort to eliminate racial inequities in NIDAs workplace, scientific… More
Accelerating the Pace of Drug Abuse Research Using Existing Data (R21 Clinical Trial Optional) RFA-DA-24-037 NIDA The purpose of this Funding Opportunity Announcement (FOA) is to invite applications proposing the innovative analysis of existing social science, behavioral, administrative, and neuroimaging data to… More
Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional) RFA-DA-22-037 NIDA The purpose of this Funding Opportunity Announcement (FOA) is to invite applications proposing the innovative analysis of existing social science, behavioral, administrative, and neuroimaging data to… More
Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed) RFA-DA-23-056 NIDA This Funding Opportunity Announcement (FOA) will support transformative research to identify and validate mechanisms, signaling pathways, and therapeutic targets, for understanding and reversing the… More
Notice of Special Interest (NOSI): High-Priority Interest to Enhance Data Science Research Training in Addiction Research NOT-DA-21-013 NIDA Data science is an important cross-cutting research approach in the NIDA Strategic Plan and increasing the capacity of experts in data science for biomedical research of addiction is critical. The… More
Notice of Special Interest (NOSI): Advancing HIV/AIDS Research through Computational Neuroscience NOT-DA-21-030 NIDA This Notice of Special Interest [NOSI] is to support computational HIV/AIDS research as it relates to NIDAs mission through collaborative research between investigators with experimental expertise… More
Notice of Special Interest: Advanced Computational Approaches to Elucidate Disease Pathology and Identify Novel Therapeutics for Addiction NOT-DA-21-004 NIDA The purpose of this Notice is to inform potential applicants to the National Institute on Drug Abuse (NIDA) of NIDA's interest in grant applications that will develop or utilize advanced… More
Developing Regulated Therapeutic and Diagnostic Solutions for Patients Affected by Opioid and/or Stimulants use Disorders (OUD/StUD) (R43/R44 - Clinical Trial Optional) RFA-DA-23-021 NIDA This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) proposing research projects, directed towards… More
Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional) PAR-22-183 NIDA The purpose of this funding opportunity announcement (FOA) is to encourage behavioral intervention development research to test efficacy, conduct clinical trials, examine mechanisms of behavior… More
Behavioral and Integrative Treatment Development Program (R01 Clinical Trial Optional) PAR-22-182 NIDA The purpose of this funding opportunity announcement (FOA) is to encourage behavioral intervention development research to test efficacy, conduct clinical trials, examine mechanisms of behavior… More
Functional Validation and/or Characterization of Genes or Variants Implicated in Substance Use Disorders (R21/R33 Clinical Trial Not Allowed) PAR-23-041 NIDA The purpose of this initiative is to support projects which exploit genome or epigenome editing to functionally validate and characterize genes or variants involved in substance use disorder-relevant… More
Avenir Award Program for Chemistry and Pharmacology of Substance Use Disorders (DP1- Clinical Trial Not Allowed) RFA-DA-24-007 NIDA oThe goal of this FOA is to attract outstanding early-stage investigators to the field of chemistry and pharmacology of substance used disorders. The award will support those in an early stage of… More
Ex Vivo Models for Studies at the Intersection of HIV and Poly-Substance Use (R01 Clinical Trial Not Allowed) RFA-DA-24-001 NIDA This Funding Opportunity Announcement (FOA) invites grant applications aimed at elucidating neuroimmune and neuronal-glial pathophysiological mechanisms of HIV-associated neurological disorders (HAND… More
NIDA Avant-Garde Program for HIV and Substance Use Disorder Research (DP1 Clinical Trial Optional) PAR-23-269 NIDA The NIDA Avant-Garde Award Program for HIV/AIDS Research supports individual scientists of exceptional creativity who propose high-impact research that will open new areas of HIV/AIDS research… More
Avenir Award Program for Research on Substance Use Disorders and HIV (DP2 Clinical Trial Optional) PAR-23-125 NIDA Avenir means future in French, and the Avenir Award Program for Research on Substance Abuse and HIV/AIDS looks toward the future by supporting early stage investigators (ESI) proposing highly… More
Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional) PAR-22-202 NIDA The purpose of this Funding Opportunity Announcement (FOA) is to accelerate the development of medication for the treatment of Substance Use Disorders (SUDs) by encouraging research applications to… More
Development of Medications to Prevent and Treat Opioid and/or Stimulant Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional) PAR-22-200 NIDA The purpose of this Funding Opportunity Announcement is to support the discovery and development of medications to prevent and treat opioid and/or psychostimulant use disorders and overdose.
More
Notice of Special Interest (NOSI): Leveraging Data Science to Bring Actionable Insights for Substance Use Prevention and Treatment NOT-DA-23-006 NIDA The purpose of this NOSI is to develop a portfolio of research projects that use data science such as predictive modeling to provide actionable insights for substance use prevention and treatment and… More
Notices of Special Interest (NOSI): High Priority Areas in Genetics, Epigenetics, and Developmental Neuroscience Branch in the Division of Neuroscience and Behavior NOT-DA-23-004 NIDA The mission of the Division of Neuroscience and Behavior (DNB) is to discover, facilitate and promote outstanding basic animal and human research aimed at identifying the causes and consequences of… More
Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1 Clinical Trial Optional) PAR-23-021 NIDA Avenir means future in French, and this award looks toward the future by supporting early stage investigators proposing highly innovative studies. The award will support those in an early stage of… More
HEAL Initiative: Career Development Awards in Implementation Science for Substance Use Prevention and Treatment (K01 - Clinical Trial Required) PAS-22-206 NIDA This HEAL FOA provides an opportunity for early career researchers or early career clinicians with foundational backgrounds in addiction to develop expertise in implementation science. Successful… More
HEAL Initiative: Career Development Awards in Implementation Science for Substance Use Prevention and Treatment (K23 - Clinical Trial Required) PAS-22-207 NIDA This HEAL FOA provides an opportunity for early career researchers or early career clinicians with foundational backgrounds in addiction to develop expertise in implementation science. Successful… More
NIDA Core "Center of Excellence" Grant Program (P30 Clinical Trial Optional) PAR-23-049 NIDA NIDA Core Center of Excellence Grants (P30) are intended to bring together investigators currently funded by NIH or other Federal or non-Federal sources, to enhance the effectiveness of existing… More
NIDA Research Center of Excellence Grant Program (P50 Clinical Trial Optional) PAR-23-076 NIDA This Funding Opportunity Announcement (FOA) is to provide support for research Centers that (1) conduct drug abuse and addiction research in any area of NIDAs mission, (2) have outstanding innovative… More
Notice of Special Interest (NOSI): Pharmacogenomic Approaches to Enhancing HIV and Substance Use Disorder (SUD) Treatment Strategies, A jump into Precision Medicine. NOT-DA-24-001 NIDA Variable responses to ART are due at least in part to human genetic variants that affect drug metabolism, drug disposition, and off-site drug targets. Defining effects of human genetic variants on… More
Otolaryngology Residency Mentored Research Pathway (R25 Clinical Trial Not Allowed) RFA-DC-20-002 NIDCD The purpose of this program is to recruit and retain outstanding, postdoctoral-level health professionals who have demonstrated potential and interest in pursuing careers as clinician-investigators.… More
NIDCD Research Opportunities for New Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional) RFA-DC-23-001 NIDCD This Funding Opportunity Announcement (FOA) solicits R01 grant applications that propose independent research projects that are within the scientific mission areas of the National Institute on… More
NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01 - Clinical Trial Required) PAR-21-064 NIDCD The NIDCD is committed to identifying effective interventions for the treatment or prevention of communication disorders by supporting welldesigned and wellexecuted clinical trials. This funding… More
NIDCD Early Career Research(ECR) Award (R21 Clinical Trial Optional) PAR-21-107 NIDCD The NIDCD Early Career Research (ECR) Award (R21) is intended to support both basic and clinical research from scientists who are beginning to establish an independent research career. It cannot be… More
NIDCD Research Career Enhancement Award for Established Investigators (K18 Independent Basic Experimental Studies with Humans Required) PAR-21-096 NIDCD The purpose of the NIDCD Research Career Enhancement Award for Established Investigators (K18) program is to enable established, proven investigators to augment or redirect their research programs… More
NIDCD Low Risk Clinical Trials in Communication Disorders (R01 Clinical Trial Required) PAR-21-063 NIDCD The NIDCD is committed to identifying effective interventions for the diagnosis, prevention, or treatment of communication disorders by supporting well-designed and well-executed clinical trials.… More
NIDCD Mentored Career Development Award for Postdoctorate Au.D./Ph.D. Audiologists (K01 Independent Basic Experimental Studies with Humans Required) PAR-21-087 NIDCD The purpose of the NIDCD Mentored Career Development Award for Postdoctorate Au.D./Ph.D. Audiologists (K01) is to support comprehensive and rigorous postdoctoral research and career development… More
NIDCD Research Career Enhancement Award for Established Investigators (K18 Independent Clinical Trial Not Allowed) PAR-21-095 NIDCD The purpose of the NIDCD Research Career Enhancement Award for Established Investigators (K18) program is to enable established, proven investigators to augment or redirect their research programs… More
NIDCD Mentored Career Development Award for Postdoctorate Au.D./Ph.D. Audiologists (K01 No Independent Clinical Trials) PAR-21-086 NIDCD The purpose of the NIDCD Mentored Career Development Award for Postdoctorate Au.D./Ph.D. Audiologists (K01) is to support comprehensive and rigorous postdoctoral research and career development… More
NIDCD Research Dissertation Fellowship for Au.D. Audiologists (F32) PAR-21-093 NIDCD The purpose of the NIDCD Research Dissertation Fellowship for Au.D. Audiologists (F32) program is to support a comprehensive, rigorous biomedical research training, and dissertation research leading… More
NIDCD Research Career Enhancement Award for Established Investigators (K18 Clinical Trial Required) PAR-21-094 NIDCD The purpose of the NIDCD Research Career Enhancement Award for Established Investigators (K18) program is to enable established, proven investigators to augment or redirect their research programs… More
NIDCD Mentored Career Development Award for Postdoctorate Au.D./Ph.D. Audiologists (K01 Clinical Trial Required) PAR-21-085 NIDCD The purpose of the NIDCD Mentored Career Development Award for Postdoctorate Au.D./Ph.D. Audiologists (K01) is to support comprehensive and rigorous postdoctoral research and career development… More
Research Experiences to Enhance Clinician-Scientists' Participation in NIDCDs Research (R25 Clinical Trial Not Allowed) PAR-21-188 NIDCD The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this R25 program is to support educational activities that… More
Mentoring Networks to Enhance Diversity in NIDCD's Extramural Research Workforce (R25 Clinical Trial Not Allowed) PAR-21-185 NIDCD The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this R25 program is to support educational activities that… More
NIDCD's Mentoring Networks to Enhance Clinician-Scientists' Participation in Research (R25 Clinical Trial Not Allowed) PAR-21-187 NIDCD The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this R25 program is to support educational activities that… More
Enhancing NIDCD's Extramural Workforce Diversity through Research Experiences (R25 Clinical Trial Not Allowed) PAR-21-186 NIDCD The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this R25 program is to support educational activities that… More
NIDCD Research Grants for Translating Basic Research into Clinical Tools (R01 Clinical Trial Optional) RFA-DC-22-001 NIDCD This Funding Opportunity Announcement (FOA) is intended to provide an avenue for basic scientists, clinicians and clinical scientists to jointly initiate and conduct translational research projects… More
NIDCD Clinical Research Center Grant (P50 Clinical Trial Optional) PAR-22-025 NIDCD The National Institute on Deafness and Other Communication Disorders (NIDCD) invites applications for Clinical Research Center Grants designed to advance the diagnosis, prevention, treatment, and… More
Advancing HIV/AIDS Research within the Mission of the NIDCD (R01 Clinical Trial Optional) PAR-23-099 NIDCD The purpose of this Funding Opportunity Announcement (FOA) is to stimulate HIV/AIDS research within the scientific mission areas of the National Institute on Deafness and Other Communications… More
Notice of Special Interest (NOSI): Fundamental Science Research on the Neural Circuits Underlying Sensory Processing NOT-DC-23-001 NIDCD The National Institute on Deafness and Other Communication Disorders (NIDCD) is issuing this Notice to highlight priorities, from its new strategic plan, in basic and mechanistic research on neural… More
Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional) PAR-23-106 NIDCD The purpose of this Funding Opportunity Announcement (FOA) is to stimulate HIV/AIDS research within the scientific mission areas of the National Institute on Deafness and Other Communications… More
Planning for the TMD Collaborative for IMproving PAtient-Centered Translational Research (TMD IMPACT) (R34 Clinical Trial Not Allowed) RFA-DE-23-014 NIDCR To support planning Grant applications that conceptualize the design and implementation of a future national, interdisciplinary, patient-centered research collaborative that will advance… More
Enabling Technologies to Accelerate Development of Oral Biodevices (R21 Clinical Trial Not Allowed) PAR-20-232 NIDCR This Funding Opportunity Announcement (FOA) invites exploratory/developmental applications that propose transformative engineering solutions to technical challenges associated with meaningful… More
Enabling Technologies to Accelerate Development of Oral Biodevices (R01 Clinical Trial Not Allowed) PAR-20-233 NIDCR This Funding Opportunity Announcement (FOA) invites applications that propose transformative engineering solutions to technical challenges associated with new development, substantial optimization of… More
Notice of Special Interest (NOSI) of NIDCR in Supporting Dental, Oral, and Craniofacial Research Using Bioinformatic, Computational, and Data Science Approaches NOT-DE-20-006 NIDCR Notice Special Interest NOSI) NIDCR Supporting Dental, Oral, Craniofacial Research Using Bioinformatic, Computational, Data Science Approaches Notice Number: NOT-DE-20-006 Key Dates Release Date:… More
National Dental Practice-Based Research Network Clinical Trial or Observational Study Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Optional) PAR-20-306 NIDCR This Funding Opportunity Announcement (FOA) is soliciting applications for clinical trials and large clinical observational studies to be conducted in the National Dental PBRN through a milestone-… More
NIDCR Dual Degree Dentist Scientist Predoctoral to Postdoctoral Transition Award (F99/K00 Independent Clinical Trial Not Allowed) PAR-21-108 NIDCR The purpose of the NIDCR Dual Degree Dentist Scientist Predoctoral to Postdoctoral Transition Award (F99/K00) is to provide support and mentorship to outstanding students enrolled in integrated dual… More
NIDCR Small Grant Program for New Investigators (R03 Clinical Trial Not Allowed) PAR-21-084 NIDCR The NIDCR Small Grant Program for New Investigators (R03) supports basic and clinical research conducted by scientists who are in the early stages of establishing an independent research career in… More
NIDCR Predoctoral to Postdoctoral Transition Award for a Diverse Dental, Oral and Craniofacial Research Workforce (F99/K00 Independent Clinical Trial Not Allowed) PAR-21-060 NIDCR The purpose of the NIDCR Predoctoral to Postdoctoral Transition Award for a Diverse Dental, Oral and Craniofacial Research Workforce (F99/K00) is to support outstanding graduate students from diverse… More
Continuation or Revision of NIDCR Clinical Trial Implementation Cooperative Agreement (UH3 Clinical Trial Required) PAR-22-068 NIDCR This Funding Opportunity Announcement (FOA) will accept applications for competing renewal or competitive revisions of ongoing clinical trials supported by the National Institute of Dental and… More
NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required) PAR-21-317 NIDCR The purpose of this Funding Opportunity Announcement (FOA) is to encourage UG3/UH3 phased cooperative agreement research applications to plan and implement behavioral and social intervention clinical… More
NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required) PAR-21-160 NIDCR The purpose of this Funding Opportunity Announcement (FOA) is to seek UG3/UH3 phased cooperative agreement research applications to plan and implement clinical trials within the mission of NIDCR.… More
NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22 Clinical Trial Required) PAR-22-045 NIDCR The purpose of the NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22) program is to provide highly qualified dentists in NIH Intramural postdoctoral fellowship… More
NIDCR Mentored Career Development Award to Promote Diversity (K01 Independent Clinical Trial Not Allowed) PAR-22-050 NIDCR The purpose of the NIDCR Mentored Career Development Award to Promote Diversity in the Dental, Oral and Craniofacial Workforce is to support postdoctoral fellows and early career faculty from diverse… More
NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00 Clinical Trial Not Allowed) PAR-22-041 NIDCR The purpose of the NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00) program is to develop and maintain a strong cohort of independent dentist scientists. This program is… More
NIDCR Mentored Career Development Award to Promote Diversity (K01 Independent Basic Experimental Studies with Humans Required) PAR-22-052 NIDCR The purpose of the NIDCR Mentored Career Development Award to Promote Diversity is to support postdoctoral fellows and early career faculty from diverse backgrounds, including those from groups… More
NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22 Clinical Trial Not Allowed) PAR-22-044 NIDCR The purpose of the NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22) program is to provide highly qualified dentists in NIH Intramural postdoctoral fellowship… More
NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00 Basic Experimental Studies Involving Humans Required) PAR-22-043 NIDCR The purpose of the NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00) program is to develop and maintain a strong cohort of independent dentist scientists. This program is… More
NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22 Basic Experimental Studies Involving Humans Required) PAR-22-046 NIDCR The purpose of the NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22) program is to provide highly qualified dentists in NIH Intramural postdoctoral fellowship… More
Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed) PAR-22-060 NIDCR The purpose of the Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools is to stimulate basic and clinical research in educational institutions that provide… More
NIDCR Mentored Career Development Award to Promote Diversity (K01 Clinical Trial Required) PAR-22-051 NIDCR The purpose of the NIDCR Mentored Career Development Award to Promote Diversity is to support postdoctoral fellows and early career faculty from diverse backgrounds, including those from groups… More
NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00 Clinical Trial Required) PAR-22-042 NIDCR The purpose of the NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00) program is to develop and maintain a strong cohort of independent dentist scientists. This program is… More
Short-term Mentored Career Enhancement Award in Dental, Oral, and Craniofacial Research for Mid-Career and Senior Investigators (K18- Independent Clinical Trial Not Allowed) PAR-22-121 NIDCR The purpose of the NIDCR Short-term Mentored Career Enhancement (K18) awards in dental, oral, and craniofacial (DOC) research is to provide mid-career and senior investigators with short-term (2.5… More
NIDCR Small Research Grants for Oral Health Data Analysis and Statistical Methodology Development (R03 Clinical Trial Not Allowed) PAR-22-160 NIDCR The goal of this funding opportunity announcement is to support meritorious research projects that involve secondary statistical analyses of existing dental, oral or craniofacial database resources,… More
Human Islet Research Network (HIRN) Pancreas Knowledgebase Program (PanKbase) (U24 - Clinical Trial Not Allowed) RFA-DK-22-018 NIDDK The purpose of this Funding Opportunity Announcement (FOA) is to continue development and expansion of the NIDDK Information Network (dkNET) under the direction of the dkNET Coordinating Unit (dkNET-… More
NIDDK Information Network Coordinating Unit: dkNET-CU (U24 Clinical Trial Not Allowed) RFA-DK-22-017 NIDDK The purpose of this Funding Opportunity Announcement (FOA) is to continue development and expansion of the NIDDK Information Network (dkNET) under the direction of the dkNET Coordinating Unit (dkNET-… More
Advancing Research on Mechanisms and Management of Pain for Diseases and Conditions within NIDDK Mission Areas (R01 Clinical Trial Optional) RFA-DK-23-006 NIDDK The impact of pain on patient quality of life for diseases and conditions within the mission of the NIDDK is enormous. Despite prior research efforts, our understanding of the underlying biological… More
Catalytic Tool and Technology Development in Kidney, Urologic, and Hematologic Diseases (R21 Clinical Trial Not Allowed) PAR-20-140 NIDDK The purpose of this Funding Opportunity Announcement is to promote development of innovative, enabling tools and technologies in the areas of kidney, urologic, and hematologic diseases.
Limited Competition for the Continuation of the Rare and Atypical Diabetes NeTwork (RADIANT) Specialized Study Centers (U54 - Clinical Trial Not Allowed) RFA-DK-22-511 NIDDK This Funding Opportunity Announcement (FOA) invites applications from the two previously funded Rare and Atypical DIAbetes NeTwork (RADIANT) research centers to further study rare and atypical forms… More
Silvio O. Conte Digestive Diseases Research Core Centers (P30 Clinical Trial Optional) RFA-DK-21-026 NIDDK This Funding Opportunity Announcement (FOA) invites applications for Silvio O. Conte Digestive Diseases Research Core Centers (DDRCCs). The DDRCCs are part of an integrated program of digestive and… More
Pilot and Feasibility Studies to Facilitate the Use of Diabetes Self-Management Education and Support to Improve Diabetes Care (R34 Clinical Trial Required) RFA-DK-20-032 NIDDK The purpose of this funding opportunity announcement (FOA) is to test an innovative and pragmatic approach to address barriers to and facilitate greater use of diabetes self-management education and… More
Notice of Special Interest: Kidney Precision Medicine Technology Development and Translation NOT-DK-21-007 NIDDK This NOSI intends to encourage small businesses to translate kidney precision medicine discoveries and technologies.
Identification and Characterization of Bioactive Microbial Metabolites for Advancing Research on Microbe-Diet-Host Interactions (R01 Clinical Trial Not Allowed) PAR-21-253 NIDDK The purpose of the Funding Opportunity Announcement is to invite applications to identify and characterizemicrobial metabolites that will establish causal associations between microbial metabolism… More
Fostering Research With Additional Resources and Development (FORWARD) Urology Centers (P20 Clinical Trial Not Allowed) RFA-DK-22-027 NIDDK The overall goal of the Fostering Research with Additional Resources and Development (FORWARD) Urology Centers program is to foster and expand the urology (excluding cancer) research community. The… More
Pilot Interventions to Integrate Social Care and Medical Care to Improve Health Equity (R01 Clinical Trial Required) RFA-DK-22-038 NIDDK This NIDDK Funding Opportunity Announcement will support pilot and feasibility trials to test interventions that involve screening for and addressing adverse social determinants of health (SDoH),… More
Postbaccalaureate Research Education Program in Diabetes, Endocrinology and Metabolic Diseases (R25 Independent Clinical Trial not Allowed) RFA-DK-22-037 NIDDK This Funding Opportunity Announcement (FOA) provides support to eligible, domestic institutions to develop and implement Postbaccalaureate Research Education Programs in Diabetes, Endocrinology and… More
Collaborative Research Using Biosamples from Type 1 Diabetes Clinical Studies (R01 - Clinical Trial Not Allowed) RFA-DK-22-021 NIDDK This Funding Opportunity Announcement (FOA) invites applications for studies of type 1 diabetes etiology and pathogenesis using data and samples from clinical trials and studies. This opportunity is… More
Clinical, Behavioral, and Physiological Studies of Open- and Closed-loop Platforms: Toward Personalized, Fully Automated, Accessible Systems (R01 Clinical Trial Required) RFA-DK-22-020 NIDDK The purpose of this fundng opportunity announcemnt (FOA) is to promote clinical research using current and emerging technologies to address barriers that limit progress toward physiological… More
Ancillary Studies to the NIDDK Inflammatory Bowel Disease Genetics Consortium (R01 Clinical Trial Not Allowed) RFA-DK-22-023 NIDDK The NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC), in collaboration with the International IBD Genetics Consortium, has identified over 250 susceptibility loci for IBD. The IBDGC has… More
NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Required) PAR-21-102 NIDDK This FOA invites applications for investigator-initiated, high-risk multi-center clinical trials involving m?o?r?e? ?t?h?a?n? ?o?n?e? clinical center. Proposed trials should be hypothesis-driven,… More
Priority HIV/AIDS Research within the Mission of the NIDDK (R01 Clinical Trial Optional) PAS-21-031 NIDDK This Funding Opportunity Announcement (FOA) seeks to stimulate HIV/AIDS research within the mission of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) that align with the… More
NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Not Allowed) PAR-21-103 NIDDK This FOA invites applications for investigator-initiated, high-risk multi-center observational studies involving more than one clinical center. Proposed studies should be hypothesis-driven and focus… More
Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of the NIDDK (R21 Clinical Trial Not Allowed) PAR-21-062 NIDDK This Funding Opportunity Announcement (FOA) invites applications for innovative basic and translational pilot research projects within the mission of the NIDDK that are aligned with NIH HIV/AIDS… More
Limited Competition: NIDDK Program Projects (P01 Clinical Trial Optional) PAR-23-121 NIDDK New biologic knowledge will come from both sole investigators following their vision and from teams of scientists sharing their expertise. Some complex biomedical problems require a multidisciplinary… More
NIDDK High Risk Multi-Center Clinical Study Implementation Planning Cooperative Agreements (U34 Clinical Trial Optional) PAR-21-101 NIDDK NIDDK supports investigator-initiated, high-risk multi-center (more than one center) clinical studies through a two-part process that may include an implementation planning cooperative agreement (U34… More
Pilot and Feasibility Trials on the Integration of Social and Medical Care for Type 1 Diabetes Mellitus (R01 Clinical Trial Required) RFA-DK-22-028 NIDDK The purpose of this NIDDK Funding Opportunity Announcement (FOA) is to support pilot and feasibility trials to test pragmatic interventions that include screening for adverse social determinants of… More
New Directions in Hematology Research (SHINE-II) (R01 Clinical Trial Optional) PAS-21-150 NIDDK This Funding Opportunity Announcement (FOA) seeks innovative grant applications in nonmalignant hematology research that will steer the field in new directions. Applications to this FOA should… More
Small Grants for New Investigators to Promote Diversity in Health-Related Research (R21 Clinical Trial Optional) PAR-21-313 NIDDK The purpose of this Funding Opportunity Announcement (FOA) is to provide support for new investigators from diverse backgrounds, including from groups nationally underrepresented in biomedical… More
Time-Sensitive Obesity Policy and Program Evaluation (R01 Clinical Trial Not Allowed) PAR-21-305 NIDDK This Funding Opportunity Announcement (FOA) establishes an accelerated review/award process to support time-sensitive research to evaluate a new policy or program that is likely to influence obesity… More
High Impact, Interdisciplinary Science in NIDDK Research Areas (RC2 Clinical Trial Optional) PAR-22-069 NIDDK The purpose of the High Impact, Interdisciplinary Science grants program is to support high impact ideas that may lay the foundation for new fields of investigation within the mission of NIDDK. The… More
Early-Stage Preclinical Validation of Therapeutic Leads for Diseases of Interest to the NIDDK (R01 Clinical Trial Not Allowed) PAR-22-111 NIDDK The goal of this Funding Opportunity Announcement (FOA) is to support translational research that provides strong justification for later-phase therapeutics discovery and development efforts in… More
Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed) PAS-22-096 NIDDK The Stimulating Hematology Investigation: New Endeavors (SHINE) program is intended to promote innovative, high-quality nonmalignant hematology research relevant to the missions of the National… More
KUH Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 - Independent Clinical Trial Not Allowed) RFA-DK-21-033 NIDDK The purpose of the Kidney, Urology or Hematology (KUH) Predoctoral to Postdoctoral Fellow Transition Awards (F99/K00) is to recruit exceptional graduate students from diverse research fields to… More
Catalyst Award for Early-Stage Investigators (ESIs) Pursuing Research on HIV Comorbidities, Coinfections, and Complications (DP1- Clinical Trial Optional) PAR-23-024 NIDDK This Funding Opportunity Announcement (FOA) supports research from creative early stage investigators who propose highly innovative, pioneering studies with potential to open new areas of HIV/AIDS… More
Stimulating Urology Interdisciplinary Team Opportunity Research (SUITOR) (R01 Clinical Trial Optional) PAS-22-074 NIDDK The Stimulating Urology Interdisciplinary Team Opportunity Research (SUITOR) program is intended to promote innovative, high quality, interdisciplinary research relevant to the mission of the… More
NIDDK Central Repository Non-renewable Sample Access (X01 Clinical Trial Not Allowed) PAR-22-171 NIDDK The NIDDK Central Repositories house valuable biological samples and data from numerous major clinical studies. This initiative allows investigators to apply for access to non-renewable samples from… More
Limited Competition: Small Grant Program for NIDDK K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional) PAR-22-129 NIDDK The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) announces a program that provides NIDDK-supported K01, K08, K23, and K25 recipients the opportunity to apply for Small… More
Small R01s for Clinical Trials Targeting Diseases within the Mission of NIDDK (R01 Clinical Trial Required) PAS-23-086 NIDDK This Funding Opportunity Announcement encourages the submission ofpilot and feasibilityclinical trialsconducted in humans that will lay the foundation for larger clinical trials related to the… More
Accelerating Data and Metadata Standards in the Environmental Health Sciences (R24 Clinical Trial Not Allowed) RFA-ES-23-002 NIEHS The purpose of this Funding Opportunity Announcement (FOA) is to support resource projects to enable Environmental Health Sciences (EHS) communities to openly develop, extend, adapt, or refine data… More
Novel Approaches for Developmental Neurotoxicity Testing (R43/R44 Clinical Trial Not Allowed) RFA-ES-23-008 NIEHS This Notice of Funding Opportunity (NOFO) supports Phase I (R43), Phase II (R44), Direct to Phase II (R44), and Fast Track (R44) Small Business Innovative Research (SBIR) grant applications from… More
SBIR E-Learning for HAZMAT and Emergency Response (R43/R44 Clinical Trial Not Allowed) RFA-ES-23-005 NIEHS This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to further the development of… More
CCRP Initiative: Chemical Threat Agent-induced Pulmonary and Ocular Pathophysiological Mechanisms (R01 Clinical Trial Not Allowed) RFA-ES-21-006 NIEHS The purpose of this Funding Opportunity Announcement (FOA) is to support research seeking to understand mechanisms of chemical toxicity and to identify potential molecular/genetic targets that reduce… More
Exploratory Grants for Climate Change and Health Research Center Development (P20 Clinical Trial Optional) RFA-ES-23-007 NIEHS The purpose of this Funding Opportunity Announcement (FOA) is to solicit P20 planning grant applications for Climate Change and Health Research Centers (CCHRCs). This program will support the… More
Virtual Consortium for Translational/Transdisciplinary Environmental Research (ViCTER) (R01 Clinical Trial Optional) RFA-ES-21-007 NIEHS The purpose of the ViCTER program is to use the R01 mechanism to foster and promote early-stage transdisciplinary collaborations and/or translational research efforts to address fundamental research… More
Maintaining and Enriching Environmental Epidemiology Cohorts to Support Scientific and Workforce Diversity (U24 Clinical Trial Not Allowed) RFA-ES-23-003 NIEHS The purpose of this Funding Opportunity Announcement (FOA) is to solicit grant applications that propose to: (1) support the maintenance and resource infrastructure enrichment for existing… More
Environmental Health Sciences Core Centers (EHSCC) (P30 Clinical Trial Optional) RFA-ES-22-010 NIEHS This Funding Opportunity Announcement (FOA) invites grant applications for Environmental Health Sciences Core Centers (EHS CC). As intellectual hubs for environmental health research, the EHS CC is… More
Transition to Independent Environmental Health Research (TIEHR) Career Award (K01 Independent Basic Experimental Studies with Humans Required) PAR-21-170 NIEHS The Transition to Independent Environmental Health (TIEHR) Career Award is a 3-year bridge scholar development program for newly independent faculty who intend to pursue research careers in… More
Transition to Independent Environmental Health Research (TIEHR) Career Award (K01 Clinical Trial Required) PAR-21-171 NIEHS The Transition to Independent Environmental Health (TIEHR) Career Award is a 3-year bridge scholar development program for newly independent faculty who intend to pursue research careers in… More
Transition to Independent Environmental Health Research (TIEHR) Career Award (K01 Clinical Trial Not Allowed) PAR-21-172 NIEHS The Transition to Independent Environmental Health (TIEHR) Career Award is a 3-year bridge scholar development program for newly independent faculty who intend to pursue research careers in… More
Research to Action: Assessing and Addressing Community Exposures to Environmental Contaminants (R01 Clinical Trial Optional) PAR-22-210 NIEHS This Funding Opportunity Announcement encourages applications using community-engaged research methods to investigate the potential health risks of environmental exposures of concern to the community… More
Time-Sensitive Research Opportunities in Environmental Health Sciences (R21 Clinical Trial Not Allowed) RFA-ES-23-004 NIEHS This funding opportunity announcement (FOA) is intended to support novel environmental health research in which an unpredictable event or policy change provides a limited window of opportunity to… More
Biomedical Data Repository (U24 - Clinical Trials Not Allowed) PAR-23-079 NIGMS This funding opportunity announcement is designed to support biomedical data repositories. Biomedical data repositories under this announcement should have the primary function to ingest, archive,… More
Biomedical Knowledgebase (U24 - Clinical Trials Not Allowed) PAR-23-078 NIGMS This funding opportunity announcement is designed to support biomedical knowledgebases. Biomedical knowledgebases under this announcement should have the primary function to extract, accumulate,… More
National Institute of General Medical Sciences Institutional Predoctoral Research Training Grant (T32 - Clinical Trial Not Allowed) PAR-20-213 NIGMS The goal of the National Institute of General Medical Sciences (NIGMS) Ruth L. Kirschstein National Research Service Award (NRSA) Predoctoral Institutional Research Training Grant (T32) program is to… More
Maximizing Access to Research Careers (T34 - Clinical Trial Not Allowed) PAR-21-147 NIGMS The goal of the Maximizing Access to Research Careers (MARC) program is to develop a diverse pool of undergraduates who complete their baccalaureate degree, and transition into and complete… More
Undergraduate Research Training Initiative for Student Enhancement (U-RISE) (T34 - Clinical Trial Not Allowed) PAR-21-146 NIGMS The goal of the Undergraduate Research Training Initiative for Student Enhancement (U-RISE) program is to develop a diverse pool of undergraduates who complete their baccalaureate degree, and… More
Notice of Special Interest (NOSI): Administrative Supplements for Equipment Purchases for Select NIGMS-Funded Awards NOT-GM-22-017 NIGMS The National Institute of General Medical Sciences (NIGMS) announces the availability of funds for administrative supplements to NIGMS-funded R01, R15, R16, R35 and R37 research projects and to… More
Coordination Center for the Models of Infectious Disease Agent Study (MIDAS) Program (R24 Clinical Trial Not Allowed) PAR-23-129 NIGMS The Coordination Center for the Models of Infectious Disease Agent Study (MIDAS) program will advance infectious disease modeling science by serving as a hub for collaboration and dissemination of… More
Modules for Enhancing Biomedical Research Workforce Training (R25 Clinical Trial Not Allowed) PAR-20-296 NIGMS The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this R25 program is to support educational activities that… More
Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed) PAR-21-169 NIGMS SuRE is a research capacity building program designed to develop and sustain research excellence in U.S. higher education institutions that receive limited NIH research support and serve students… More
Notice of Special Interest: NIGMS Priorities for Small Business Development of Sepsis Diagnostics and Therapeutics NOT-GM-20-028 NIGMS Notice Special Interest: NIGMS Priorities Small Business Development Sepsis Diagnostics Therapeutics Notice Number: NOT-GM-20-028 Key Dates Release Date: June 2, 2020 First Available Due Date:… More
National Institute of General Medical Sciences (NIGMS) Bridges to the Doctorate (T32) PAR-21-198 NIGMS The goal of the Bridges to the Doctorate Research Training program is to develop a diverse pool of scientists earning a Ph.D., who have the skills to successfully transition into careers in the… More
Research on Interventions that Promote the Careers of Individuals in the Biomedical Research Enterprise (R01 Clinical Trial Not Allowed) PAR-21-269 NIGMS This Funding Opportunity Announcement (FOA) encourages solicits applications that propose research designed to test training, mentoring, and networking interventions intended to enhance research-… More
Innovative Programs to Enhance Research Training (IPERT) (R25 Independent Clinical Trial Not Allowed) PAR-21-196 NIGMS The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NIGMS R25 program is to support educational activities… More
Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Institutionally-Focused Research Education Award to Promote Diversity (UE5 - Clinical Trial Not Allowed) PAR-21-277 NIGMS The NIH Research Education Program (UE5) supports research education activities in the mission areas of the NIH. The over-arching goal of the MOSAIC UE5 program is to support educational activities… More
Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed) PAR-21-173 NIGMS SuRE is a research capacity building program designed to develop and sustain research excellence in U.S. higher education institutions that receive limited NIH research support and serve students… More
Medical Scientist Training Program (T32) PAR-21-189 NIGMS The goal of the Medical Scientist Training Program (MSTP) is to develop a diverse pool of highly trained physician-scientist leaders available to meet the needs of the Nations biomedical research… More
Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed) PAR-21-155 NIGMS The purpose of this Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions is to support small scale research grants at institutions that do not receive substantial funding… More
NIGMS National and Regional Resources (R24 - Clinical Trial Not Allowed) PAR-22-065 NIGMS This Funding Opportunity Announcement (FOA) encourages applications for support of national or regional resources that will provide access to state-of-the-art facilities, equipment, technologies,… More
National Centers for Cryoelectron Microscopy (R24 Clinical Trial Not Allowed) PAR-23-118 NIGMS This initiative will support national service centers for molecular structure determination by high resolution cryoelectron microscopy (cryoEM). The centers will provide access to state-of-the-art… More
Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed) PAR-21-271 NIGMS The purpose of the MOSAIC Postdoctoral Career Transition Award to Promote Diversity (K99/R00) program is to support a cohort of early career, independent investigators from diverse backgrounds… More
National Institute of General Medical Sciences (NIGMS) Bridges to the Baccalaureate Research Training Program (T34) PAR-22-125 NIGMS The goal of the Bridges to the Baccalaureate Research Training Program is to provide structured activities to prepare a diverse cohort of research-oriented students to transfer from associate degree-… More
Institutional Research and Academic Career Development Awards (IRACDA) (K12 - Independent Clinical Trial Not Allowed) PAR-22-212 NIGMS The Institutional Research and Academic Career Development Award (IRACDA) Program provides support for a mentored postdoctoral research experience at a research-intensive institution combined with an… More
Postdoctoral Research Associate Training (PRAT) Program (Fi2) PAR-22-191 NIGMS The NIGMS Postdoctoral Research Associate Training (PRAT) Programs overarching goal is to provide high quality postdoctoral research training in the basic biomedical sciences to a diverse group of… More
Limited Competition: NIGMS Mature Synchrotron Resources for Structural Biology (P30 - Clinical Trial Not Allowed) PAR-22-166 NIGMS This Funding Opportunity Announcement (FOA) encourages applications for support of mature structural biology resources at synchrotron facilities. Mature refers to the techniques made available at… More
Notice of Special Interest (NOSI): Inclusion of Economic Factors and Outcomes in Infectious Disease Modeling Studies NOT-GM-22-021 NIGMS The National Institute of General Medical Sciences (NIGMS) is issuing this Notice to highlight interest in receiving grant applications focused on infectious disease modeling research that… More
Leading Equity and Diversity in the Medical Scientist Training Program (LEAD MSTP)(T32) PAR-23-030 NIGMS The goal of the Leading Equity and Diversity in the Medical Scientist Training Program (LEAD MSTP) is to develop a diverse pool of highly trained clinician-scientist leaders available to meet the… More
Centers of Biomedical Research Excellence (COBRE) Phase 1 (P20 - Clinical Trial Optional) PAR-22-250 NIGMS The National Institute of General Medical Sciences (NIGMS) invites applications for renewal of eligible Centers of Biomedical Research Excellence (COBRE) grants. The objective of the COBRE initiative… More
Postbaccalaureate Research Education Program (PREP)(R25 - Independent Clinical Trial Not Allowed) PAR-22-220 NIGMS This funding opportunity announcement (FOA) provides support to eligible, domestic institutions to develop and implement effective, evidence-informed approaches to biomedical research education and… More
Technology Development Research for Establishing Feasibility and Proof of Concept (R21 - Clinical Trial Not Allowed) PAR-22-126 NIGMS This initiative will support exploratory research leading to the development of innovative technologies for biomedical research. The program will recognize and reward high risk approaches with… More
Focused Technology Research and Development (R01 Clinical Trial Not Allowed) PAR-22-127 NIGMS This initiative will support projects that focus solely on development of technologies with the potential to enable acquisition of basic biomedical knowledge. Projects should be justified in terms of… More
Maximizing Investigators' Research Award (R35 - Clinical Trial Optional) PAR-22-180 NIGMS The Maximizing Investigators' Research Award (MIRA) provides support for the program of research in an investigator's laboratory that is within the mission of NIGMS. The goal of MIRA is to… More
IDeA Networks of Biomedical Research Excellence (INBRE) (P20 Clinical Trial Optional) PAR-23-100 NIGMS The National Institute of General Medical Sciences (NIGMS) invites applications for Institutional Development Award (IDeA) Networks of Biomedical Research Excellence (INBRE) awards from investigators… More
Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) (P20 - Clinical Trial Optional) PAR-23-063 NIGMS The Centers of Biomedical Research Excellence (COBRE) program supports the establishment and development of innovative biomedical and behavioral research centers at Institutional Development Award (… More
Instrumentation Grant Program for Resource-Limited Institutions (S10 - Clinical Trial Not Allowed) PAR-23-138 NIGMS The Instrumentation Grant Program for Resource-Limited Institutions supports the purchase of state-of-the-art scientific instruments to enhance the research and educational missions of resource-… More
Biomedical Technology Optimization and Dissemination Center (BTOD)(RM1-Clinical Trial Not Allowed) PAR-23-110 NIGMS This Funding Opportunity Announcement (FOA) encourages applications for NIGMS Biomedical Technology Optimization and Dissemination (BTOD) Centers to support late-stage technology optimization and… More
Collaborative Program Grant for Multidisciplinary Teams (RM1 - Clinical Trial Optional) PAR-23-077 NIGMS This funding opportunity announcement (FOA) is designed to support highly integrated research teams of three to six PD/PIs to address ambitious and challenging research questions that are important… More
Research With Activities Related to Diversity (ReWARD) (R01 Clinical Trial Optional) PAR-23-122 NIGMS The NIH ?Research With Activities Related to Diversity (ReWARD) Program's overarching goal is to enhance the breadth and geographical location of research and research-related activities… More
SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance (SB1, Clinical Trial Not Allowed) PAR-20-128 NIH The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications from small business concerns (SBCs) to the newly re-authorized Commercialization Readiness Pilot (CRP) program… More
SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1 Clinical Trial Required) PAR-20-130 NIH The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications from small business concerns (SBCs) to the newly re-authorized Commercialization Readiness Pilot (CRP) program… More
SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, Clinical Trial Not Allowed) PAR-20-129 NIH The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications from small business concerns (SBCs) to the newly re-authorized Commercialization Readiness Pilot (CRP) program… More
Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Required) PA-20-206 NIH The purpose of the NIH Mentored Patient-Oriented Research Career Development Award (K23) is to support the career development of individuals with a clinical doctoral degree who have made a commitment… More
Mentored Research Scientist Development Award (Parent K01 Independent Basic Experimental Studies with Humans Required) PA-20-191 NIH The purpose of the NIH Mentored Research Scientist Development Award (K01) is to provide support and protected time (three to five years) for an intensive, supervised career development experience in… More
NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) PA-20-185 NIH The NIH Research Project Grant supports a discrete, specified, circumscribed project in areas representing the specific interests and competencies of the investigator(s). The proposed project must be… More
Mentored Quantitative Research Development Award (Parent K25 Independent Basic Experimental Studies with Humans Required) PA-20-198 NIH The purpose of the Mentored Quantitative Research Career Development Award (K25) is to attract to NIH-relevant research those investigators whose quantitative science and engineering research has… More
Independent Scientist Award (Parent K02 - Independent Clinical Trial Not Allowed) PA-20-174 NIH The purpose of the NIH Independent Scientist Award (K02) is to foster the development of outstanding scientists and enable them to expand their potential to make significant contributions to their… More
NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed) PA-20-200 NIH The NIH Small Research Grant Program supports small research projects that can be carried out in a short period of time with limited resources. This program supports different types of projects… More
Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Required) PA-20-193 NIH The purpose of the NIH Midcareer Investigator Award in Patient-Oriented Research (K24) is to provide support to mid-career health-professional doctorates for protected time to devote to patient-… More
Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Required) PA-20-202 NIH The primary purpose of the NIH Mentored Clinical Scientist Research Career Development Awards (K08) program is to prepare qualified individuals for careers that have a significant impact on the… More
NIH Exploratory/Developmental Research Grant Program (Parent R21 Basic Experimental Studies with Humans Required) PA-20-196 NIH The NIH Exploratory/Developmental Grant supports exploratory and developmental research projects by providing support for the early and conceptual stages of these projects. These studies may involve… More
NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed) PA-20-188 NIH The purpose of the NIH Pathway to Independence Award (K99/R00) program is to increase and maintain a strong cohort of new and talented, NIH-supported, independent investigators. This program is… More
Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Not Allowed) PA-20-199 NIH The purpose of the Mentored Quantitative Research Career Development Award (K25) is to attract to NIH-relevant research those investigators whose quantitative science and engineering research has… More
Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed) PA-20-205 NIH The purpose of the NIH Mentored Patient-Oriented Research Career Development Award (K23) is to support the career development of individuals with a clinical doctoral degree who have made a commitment… More
Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed) PA-20-190 NIH The purpose of the NIH Mentored Research Scientist Development Award (K01) is to provide support and protected time (three to five years) for an intensive, supervised career development experience in… More
Research Project Grant (Parent R01 Basic Experimental Studies with Humans Required) PA-20-184 NIH The NIH Research Project Grant supports a discrete, specified, circumscribed project in areas representing the specific interests and competencies of the investigator(s).
This Parent Funding… More
Independent Scientist Award (Parent K02 Independent Basic Experimental Studies with Humans Required) PA-20-173 NIH The purpose of the NIH Independent Scientist Award (K02) is to foster the development of outstanding scientists and enable them to expand their potential to make significant contributions to their… More
NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed) PA-20-195 NIH The NIH Exploratory/Developmental Grant supports exploratory and developmental research projects by providing support for the early and conceptual stages of these projects. These studies may involve… More
Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Not Allowed) PA-20-186 NIH The purpose of the NIH Midcareer Investigator Award in Patient-Oriented Research (K24) is to provide support to mid-career health-professional doctorates for protected time to devote to patient-… More
Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Basic Experimental Studies with Humans Required) PA-20-201 NIH The primary purpose of the NIH Mentored Clinical Scientist Research Career Development Awards (K08) program is to prepare qualified individuals for careers that have a significant impact on the… More
Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Required) PA-20-176 NIH The purpose of the NIH Mentored Research Scientist Development Award (K01) is to provide support and protected time (three to five years) for an intensive, supervised career development experience in… More
NIH Pathway to Independence Award (Parent K99/R00 Independent Basic Experimental Studies with Humans Required) PA-20-189 NIH The purpose of the NIH Pathway to Independence Award (K99/R00) program is to increase and maintain a strong cohort of new and talented, NIH-supported, independent investigators. This program is… More
Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Required) PA-20-197 NIH The purpose of the Mentored Quantitative Research Career Development Award (K25) is to attract to NIH-relevant research those investigators whose quantitative science and engineering research has… More
Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Basic Experimental Studies with Humans Required) PA-20-204 NIH The purpose of the NIH Mentored Patient-Oriented Research Career Development Award (K23) is to support the career development of individuals with a clinical doctoral degree who have made a commitment… More
Midcareer Investigator Award in Patient-Oriented Research (Parent K24 - Independent Basic Experimental Studies with Humans Required) PA-20-192 NIH The purpose of the NIH Midcareer Investigator Award in Patient-Oriented Research (K24) is to provide support to mid-career health-professional doctorates for protected time to devote to patient-… More
Research Project Grant (Parent R01 Clinical Trial Required) PA-20-183 NIH The NIH Research Project Grant supports a discrete, specified, circumscribed project in areas representing the specific interests and competencies of the investigator(s). This Parent Funding… More
Independent Scientist Award (Parent K02 - Independent Clinical Trial Required) PA-20-171 NIH The purpose of the NIH Independent Scientist Award (K02) is to foster the development of outstanding scientists and enable them to expand their potential to make significant contributions to their… More
Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Not Allowed) PA-20-203 NIH The primary purpose of the NIH Mentored Clinical Scientist Research Career Development Awards (K08) program is to prepare qualified individuals for careers that have a significant impact on the… More
NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required) PA-20-194 NIH The NIH Exploratory/Developmental Grant supports exploratory and developmental research projects by providing support for the early and conceptual stages of these projects. These studies may involve… More
NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Required) PA-20-187 NIH The purpose of the NIH Pathway to Independence Award (K99/R00) program is to increase and maintain a strong cohort of new and talented, NIH-supported, independent investigators. This program is… More
Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional) PA-20-135 NIH The National Institutes of Health (NIH) hereby notify the applicant community that funds may be available for applications based on a presidentially declared disaster under the Stafford Act, a public… More
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32) PA-21-048 NIH The purpose of the Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32) is to support research training of highly promising postdoctoral… More
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31-Diversity) PA-21-052 NIH The purpose of this Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research award is to enhance the diversity of… More
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Senior Fellowship (Parent F33) PA-21-047 NIH The National Institutes of Health (NIH) awards senior individual research training fellowships to experienced scientists who wish to make major changes in the direction of their research careers or… More
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions with NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30) PA-21-049 NIH This Funding Opportunity Announcement (FOA) will support students at institutions with NIH-funded institutional predoctoral dual-degree training programs. The purpose of the Kirschstein-NRSA, dual-… More
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31) PA-21-051 NIH The purpose of the Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31) award is to enable promising predoctoral students to obtain individualized… More
Limited Competition: Lasker Clinical Research Scholars Transition Award (R00 Clinical Trial Optional) PAR-20-315 NIH The Lasker Clinical Research Scholars Program supports research activities during the early stage careers of independent clinical researchers. This FOA offers the opportunity for current Lasker… More
Notice of Special Interest (NOSI): Use of Digital Technology and Mobile Health (mHealth) to Improve Diagnosis, Assessments, Interventions, Management and Outcomes for Individuals with Down Syndrome Across the Lifespan (R21 Clinical Trial Not Allowed) NOT-OD-21-092 NIH This Notice invites applications specifically aimed at developing or building upon existing technological tools to improve diagnosis, assessments, interventions, management, and outcomes for infants… More
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions Without NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30) PA-21-050 NIH This Funding Opportunity Announcement (FOA) will support students at institutions without NIH-funded institutional predoctoral dual-degree training programs. The purpose of the Kirschstein-NRSA, dual… More
Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Basic Experimental Studies with Humans Required) PAR-21-039 NIH The Stephen I. Katz Early Stage Investigator Research Project Grant supports an innovative project that represents a change in research direction for an early stage investigator (ESI) and for which… More
Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed) PAR-21-038 NIH The Stephen I. Katz Early Stage Investigator Research Project Grant supports an innovative project that represents a change in research direction for an early stage investigator (ESI) and for which… More
NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed) PA-21-151 NIH The purpose of the NIH Research Conference Grant (R13) is to support high quality conferences that are relevant to the public health and to the scientific mission of the participating Institutes and… More
Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R21 Clinical Trial Optional) PAR-20-159 NIMH The goal of this Funding Opportunity Announcement (FOA) is to encourage applications for studies that will enhance knowledge of mechanisms associated with neuropsychiatric symptoms (NPS) in persons… More
HIV Infection of the Central Nervous System (R01 Clinical Trial Not Allowed) PA-20-149 NIMH The goals of this Funding Opportunity Announcement (FOA) are to stimulate further research on delineating the pathophysiology of HIV-1 associated CNS disease in the setting of chronic viral… More
Notice of Special Interest: Stigma or Other Social Determinants of Health (SDOH) in HIV Prevention and Treatment NOT-MH-20-020 NIMH Notice Special Interest: Stigma Other Social Determinants Health SDOH) HIV Prevention Treatment Notice Number: NOT-MH-20-020 Key Dates Release Date: March 30, 2020 First Available Due Date: 07, 2020… More
Eradication of HIV-1 from Central Nervous system Reservoirs (R01 Clinical Trial Not Allowed) PA-20-151 NIMH This Funding Opportunity Announcement (FOA) invites research grant applications studying mechanisms of HIV-1 persistence and eradication strategies specifically focused on the central nervous system… More
Notice of Special Interest (NOSI): Strengthening the HIV Care Continuum NOT-MH-20-023 NIMH Notice Special Interest NOSI): Strengthening HIV Care Continuum Notice Number: NOT-MH-20-023 Key Dates Release Date: March 30, 2020 First Available Due Date: 07, 2020 Expiration Date: 08, 2023… More
Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R01 Clinical Trial Optional) PAR-20-157 NIMH The goal of this Funding Opportunity Announcement (FOA) is to encourage applications for studies that will enhance knowledge of mechanisms associated with neuropsychiatric symptoms (NPS) in persons… More
Advanced Laboratories for Accelerating the Reach and Impact of Treatments for Youth and Adults with Mental Illness (ALACRITY) Research Centers (P50 Clinical Trial Optional) PAR-20-293 NIMH This Funding Opportunity Announcement (FOA) invites applications for centers to support transdisciplinary teams of clinical and mental health services researchers, behavioral scientists, social… More
Understanding Suicide Risk and Protective Factors among Black Youth (R21 Clinical Trial Not Allowed) RFA-MH-22-141 NIMH Proposed as a priority under the Suicide Prevention Transformational Project Strategic Plan, this funding opportunity is aligned with NIMHs commitment to support research that builds on existing… More
Understanding Suicide Risk and Protective Factors among Black Youth (R01 Clinical Trial Not Allowed) RFA-MH-22-140 NIMH Proposed as a priority under the Suicide Prevention Transformational Project Strategic Plan, this funding opportunity is aligned with NIMHs commitment to support research that builds on existing… More
Effectiveness and Implementation Research for Post-Acute Interventions to Optimize Long-Term Mental Health Outcomes in Low- and Middle-Income Countries (R34 Clinical Trial Optional) RFA-MH-23-140 NIMH This FOA seeks research applications for effectiveness and implementation science on the post-acute (long-term or chronic) management of mental health conditions. This funding opportunity aims to… More
BRAIN Initiative: Data Archives for the BRAIN Initiative (R24 Clinical Trial Optional) RFA-MH-20-600 NIMH This Funding Opportunity Announcement (FOA) solicits applications to develop web-accessible data archives to capture, store, and curate data related to BRAIN Initiative activities. The data archives… More
Cellular and Molecular Biology of Complex Brain Disorders (R21 Clinical Trial Not Allowed) PAR-20-264 NIMH This Funding Opportunity Announcement (FOA) encourages research on the biology of high confidence risk factors associated with complex brain disorders, with a focus on the intracellular,… More
Behavioral Tasks Targeting Brain Systems Relevant to Anhedonia (R01 Basic Experimental Studies with Humans Required) PAR-20-235 NIMH This Funding Opportunity Announcement (FOA) encourages research to develop task-based behavioral measures that are shown to engage brain systems relevant to anhedonia using neuroimaging or other… More
Cellular and Molecular Biology of Complex Brain Disorders (R01 Clinical Trial Not Allowed) PAR-20-263 NIMH This Funding Opportunity Announcement (FOA) encourages research on the biology of high confidence risk factors associated with complex brain disorders, with a focus on the intracellular,… More
Notice of Special Interest to Highlight High Priority Opportunities for Intervention Development Research in Geriatric Mental Health NOT-MH-20-027 NIMH Notice Special Interest Highlight High Priority Opportunities Intervention Development Research Geriatric Mental Health Notice Number: NOT-MH-20-027 Key Dates Release Date: March 19, 2020 First… More
Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional) PAR-20-307 NIMH The National Institute of Mental Health (NIMH) Division of AIDS Research (DAR) encourages applications for Center Core grants (P30) to support HIV/AIDS Research Centers (ARC). The ARC is intended to… More
AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional) PAR-20-308 NIMH The National Institute of Mental Health (NIMH) Division of AIDS Research (DAR) encourages applications for Center Core grants (P30) to support HIV/AIDS Research Centers (ARC). The ARC is intended to… More
BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed) RFA-MH-21-175 NIMH This is a reissue of RFA-MH-19-136. The purpose of this Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative is to encourage applications that will develop and validate… More
Using Secondary Data Analysis to Determine Whether Preventive Interventions Implemented Earlier in Life Reduce Suicide Risk (U01 Clinical Trial Not Allowed) RFA-MH-23-275 NIMH The purpose of this funding opportunity announcement (FOA) is to encourage research to integrate/harmonize existing large prevention trial data sets implemented earlier in life to examine whether… More
BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science (R01 Clinical Trial Optional) RFA-MH-21-205 NIMH Reissue of RFA-MH-19-400. This funding opportunity announcement (FOA), in support of the NIH Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative, is one of several FOAs… More
BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access and Manipulation to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed) RFA-MH-21-180 NIMH This Funding Opportunity Announcement (FOA) from the NIH Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative is intended to support establishment of facilities at… More
Notice of Change to Key Dates for PAR-21-263, "Computational Approaches for Validating Dimensional Constructs of Relevance to Psychopathology (R01 Clinical Trial Optional) NOT-MH-22-180 NIMH This Notice modifies key dates for PAR-21-263
Computationally-Defined Behaviors in Psychiatry (R21 Clinical Trial Optional) PAR-21-264 NIMH Reissue of RFA-MH-19-240. This Funding Opportunity Announcement (FOA) solicits proposals for research projects that will apply computational approaches to develop parametrically detailed behavioral… More
Computational Approaches for Validating Dimensional Constructs of Relevance to Psychopathology (R01 Clinical Trial Optional) PAR-21-263 NIMH Reissue of RFA-MH-19-242.This Funding Opportunity Announcement (FOA) solicits proposals for research projects that will use computational approaches to test the validity of dimensional constructs in… More
Discovery of Cell-based Chemical Probes for Novel Brain Targets (R21 Clinical Trial Not Allowed) PAR-21-028 NIMH This Funding Opportunity Announcement (FOA) intends to support investigators who have interest and capability to join efforts for the discovery of cell-based chemical probes for novel brain targets.… More
Discovery of in vivo Chemical Probes for the Nervous System (R01 Clinical Trial Not Allowed) PAR-21-029 NIMH This Funding Opportunity Announcement (FOA) intends to support investigators who have interest and capability to join efforts for the discovery of in vivo chemical probes for novel brain targets. It… More
BRAIN Initiative Cell Atlas Network (BICAN): Specialized Collaboratory on Human, Non-human Primate, and Mouse Brain Cell Atlases (R01 Clinical Trial Not Allowed) RFA-MH-22-292 NIMH This Funding Opportunity Announcement (FOA) intends to support a group of Specialized Collaboratories that will adopt scalable technology platforms and streamlined sampling strategies and assay… More
Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required) PAR-21-134 NIMH This is a reissue of RFA-MH-18-705: Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required). As part of NIMH's clinical trials… More
Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required) PAR-21-137 NIMH This is a reissue of RFA-MH-18-702: Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R61/R33- Clinical Trial Required). NIMH requires an… More
First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Devices for Psychiatric Disorders (U01 Clinical Trial Required) PAR-21-133 NIMH The purpose of this Funding Opportunity Announcement (FOA) is to encourage cooperative agreement applications to support early stage clinical trials of novel mechanism of action, investigational… More
Clinical Trials to Test the Effectiveness of Treatment, Preventive, and Services Interventions (Collaborative R01 Clinical Trial Required) PAR-21-129 NIMH This is a reissue of RFA-MH-18-700: Clinical Trials to Test the Effectiveness of Treatment, Preventive, and Services Interventions (Collaborative R01-- Clinical Trial Required). This FOA is a key… More
BRAIN Initiative: Brain Behavior Quantification and Synchronization (R61/R33 Clinical Trial Optional) RFA-MH-23-335 NIMH The goal of this effort is to support the development and validation of next generation platforms and analytic approaches to precisely quantify behaviors in humans and link them with simultaneously… More
Clinical Trials to Test the Effectiveness of Treatment, Preventive, and Services Interventions (R01 Clinical Trial Required) PAR-21-130 NIMH This is a reissue of RFA-MH-18-701: Clinical Trials to Test the Effectiveness of Treatment, Preventive, and Services Interventions (R01 Clinical Trial Required). This FOA is a key element of NIMHs… More
Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required) PAR-21-136 NIMH This is a reissue of RFA-MH-18-703: Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required). NIMH requires an… More
Confirmatory Efficacy Clinical Trials of Non-Pharmacological Interventions for Mental Disorders (R01 Clinical Trial Required) PAR-21-132 NIMH This is a reissue of RFA-MH-18-707: Confirmatory Efficacy Clinical Trials of Non-Pharmacological Interventions for Mental Disorders (R01 Clinical Trial Required). As part of NIMH's clinical… More
Pilot Effectiveness Trials for Treatment, Preventive and Services Interventions (R34 Clinical Trial Required) PAR-21-131 NIMH This is a reissue of RFA-MH-18-706: Pilot Effectiveness Trials for Treatment, Preventive and Services Interventions (R34- Clinical Trial Required). As part of NIMH's clinical trials pipeline… More
Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33 Clinical Trial Required) PAR-21-135 NIMH This is a reissue of RFA-MH-18-704: Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33 Clinical Trial Required). As part of NIMH's clinical trials… More
Research on Autism Spectrum Disorders (R01 Clinical Trial Optional) PA-21-201 NIMH Reissue of the PA-18-401. The purpose of this Funding Opportunity Announcement (FOA) is to encourage research grant applications to support research designed to elucidate the etiology, epidemiology,… More
Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required) PAR-21-210 NIMH Reissue of PAR-18-430. NIMH seeks applications for research projects to evaluate the effectiveness of therapeutic and service delivery interventions for the post-acute management of mental health… More
Research on Autism Spectrum Disorders (R03 Clinical Trial Optional) PA-21-199 NIMH Reissue of the PA-18-399. The purpose of this Funding Opportunity Announcement (FOA) is to encourage research grant applications to support research designed to elucidate the etiology, epidemiology,… More
Pilot Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R34 Clinical Trial Required) PAR-21-211 NIMH Reissue of PAR-18-431. NIMH seeks applications for pilot effectiveness projects to evaluate the preliminary effectiveness of therapeutic and service delivery interventions for the post-acute… More
Research on Autism Spectrum Disorders (R21 Clinical Trial Optional) PA-21-200 NIMH Reissue of the PA-18-400. The purpose of this Funding Opportunity Announcement (FOA) is to encourage research grant applications to support research designed to elucidate the etiology, epidemiology,… More
Mentored Career Transition Award for Intramural Fellows (K22 Clinical Trials Not Allowed) PA-21-194 NIMH Reissue of PA-18-614. The Mentored Career Transition Award for NIMH Intramural Fellows (K22) is a two-phase, mentored career development award program that is intended to facilitate a timely… More
NIMH Exploratory/Developmental Research Grant (R21 Clinical Trial Not Allowed) PA-21-235 NIMH Reissue of PA-18-350. The NIMH Exploratory/Developmental Grant program supports exploratory and high-risk research projects that fall within the NIMH mission by providing support for the early and… More
Mentored Career Transition Award for Intramural Fellows (K22 Clinical Trials Required) PA-21-195 NIMH Reissue of PA-18-613. The Mentored Career Transition Award for NIMH Intramural Fellows (K22) is a two-phase, mentored career development award program that is intended to facilitate a timely… More
Understanding and Modifying Temporal Dynamics of Coordinated Neural Activity (R21 Clinical Trial Optional) PAR-21-176 NIMH This R21 funding opportunity encourages projects that test, in animals and/or humans, whether modifying electrophysiological patterns can improve cognitive, affective, or social processing. This R21… More
Understanding and Modifying Temporal Dynamics of Coordinated Neural Activity (R01 Clinical Trial Optional) PAR-21-175 NIMH This R01 funding opportunity encourages projects that test, in animals and/or humans, whether modifying electrophysiological patterns can improve cognitive, affective, or social processing. This R01… More
BRAIN Initiative: Integration and Analysis of BRAIN Initiative Data (R01 Clinical Trial Not Allowed) RFA-MH-22-220 NIMH This is a reissue of RFA-MH-21-135. This FOA supports the development of software to visualize and analyze the data as part of programs of building the informatics infrastructure for the BRAIN… More
BRAIN Initiative: Development of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in Human and Non-Human Primate Brain (UG3/UH3 Clinical Trial Optional) RFA-MH-22-115 NIMH Reissue of RFA-MH-19-135 The purpose of this Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative is to encourage applications that will develop and validate novel tools… More
BRAIN Initiative: Standards to Define Experiments Related to the BRAIN Initiative (R01 Clinical Trial Not Allowed) RFA-MH-22-145 NIMH Reissue of RFA-MH-20-128 This Funding Opportunity Announcement (FOA) solicits applications to develop standards that describe experimental protocols that are being conducted as part of the BRAIN… More
Innovative Mental Health Services Research Not Involving Clinical Trials (R01 Clinical Trials Not Allowed) PAR-23-095 NIMH The purpose of this funding announcement is to encourage innovative research that will inform and support the delivery of high-quality, continuously improving mental health services to benefit the… More
Effectiveness of Implementing Sustainable Evidence-Based Mental Health Practices in Low-Resource Settings to Achieve Mental Health Equity for Traditionally Underserved Populations (R01 Clinical Trial Optional) PAR-23-092 NIMH This Funding Opportunity Announcement (FOA) encourages studies that develop and test the effectiveness of strategies for implementation and sustainable delivery of evidence-based mental health… More
Initiation of a Mental Health Family Navigator Model to Promote Early Access, Engagement and Coordination of Needed Mental Health Services for Children and Adolescents (R01 Clinical Trial Required) PAR-23-094 NIMH The purpose of this Funding Opportunity Announcement (FOA) is to encourage research applications to develop and test the effectiveness and implementation of family navigator models designed to… More
Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R01 Clinical Trial Optional) PAR-23-093 NIMH The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications to pursue invasive neural recording studies focused on mental health-relevant questions. Invasive neural… More
Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R21 Clinical Trial Optional) PAR-23-101 NIMH Reissue of RFA-20-351.The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications to pursue invasive neural recording studies focused on mental health-relevant questions.… More
NIMH Research Education Mentoring Program for HIV/AIDS Researchers (R25 Clinical Trial Not Allowed) PAR-21-228 NIMH Reissue of PAR-17-485. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this National Institute of Mental… More
Pilot Studies to Test the Initiation of a Mental Health Family Navigator Model to Promote Early Access, Engagement and Coordination of Needed Mental Health Services for Children and Adolescents (R34 Clinical Trial Required) PAR-23-104 NIMH The purpose of this Funding Opportunity Announcement (FOA) is to encourage research applications to develop and pilot test the effectiveness and implementation of family navigator models designed to… More
NIMH Career Transition Award for Tenure-Track Intramural Investigators (K22 No Independent Clinical Trials) PAR-21-239 NIMH Reissue of PAR-18-755. The primary goal of the NIMH Career Transition Award for Tenure-Track Intramural Investigators (K22) Program (hereafter abbreviated as the NIMH Career Transition K22 Program)… More
Implementing and Sustaining Evidence-Based Mental Health Practices in Low-Resource Settings to Achieve Equity in Outcomes (R34 Clinical Trial Required ) PAR-23-103 NIMH Reissue of RFA-MH-20-401.This Funding Opportunity Announcement (FOA) supports pilot work for subsequent studies testing the effectiveness of strategies to deliver evidence-based mental health… More
NIMH Instrumentation Program (S10 Clinical Trial Not Allowed) RFA-MH-22-155 NIMH Reissue of RFA-MH-20-555. The NIMH Instrumentation Program encourages applications from NIH funded investigators to purchase or upgrade a single commercially available instrument or a group of… More
BRAIN Initiative: Engineering and optimization of molecular technologies for functional dissection of neural circuits (UM1 Clinical Trial Not Allowed) RFA-MH-22-245 NIMH This BRAIN Initiative FOA is to further develop molecular tools of high impact that are targetable to brain cell types for the monitoring and manipulation of neural circuits in experimental animals… More
Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional) PAR-23-097 NIMH The purpose of this FOA is to advance translational research to better understand the emergence and worsening of mood and psychotic disorders (e.g., perimenopausal depression (PMD), generalized… More
Drug Discovery For Nervous System Disorders (R01 Clinical Trials Not Allowed) PAR-22-031 NIMH Reissue of PAR-19-147 This Funding Opportunity Announcement (FOA) supports the discovery of novel compounds for the prevention and treatment of nervous system disorders.
Through this FOA NIMH… More
Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional) PAR-23-102 NIMH Reissue of RFA-MH-21-106 The purpose of this FOA is to advance translational research to better understand the emergence and worsening of mood and psychotic disorders (e.g., perimenopausal depression… More
Basic Neurodevelopmental Biology of Circuits and Behavior (R01 Clinical Trial Not Allowed) PAR-22-066 NIMH Reissue of PAR-19-027 This Funding Opportunity Announcement (FOA) solicits research projects focused on the dynamic and mechanistic links between the maturation of brain circuits and behaviors across… More
Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Not Allowed) PAR-22-038 NIMH Reissue of PAR-18-941. The purpose of this funding opportunity announcement (FOA) is to encourage applications seeking to develop the next generation of brain stimulation devices for treating mental… More
Drug Discovery For Nervous System Disorders (R21 Clinical Trials Not Allowed) PAR-22-032 NIMH Reissue of PAR-19-146 This Funding Opportunity Announcement (FOA) supports the discovery of novel compounds for the prevention and treatment of nervous system disorders.
Through this FOA NIMH… More
Neuromodulation/